WO2024083600A1 - Bactéries de lutte contre les odeurs - Google Patents
Bactéries de lutte contre les odeurs Download PDFInfo
- Publication number
- WO2024083600A1 WO2024083600A1 PCT/EP2023/078168 EP2023078168W WO2024083600A1 WO 2024083600 A1 WO2024083600 A1 WO 2024083600A1 EP 2023078168 W EP2023078168 W EP 2023078168W WO 2024083600 A1 WO2024083600 A1 WO 2024083600A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bacillus
- strain
- acid
- accession number
- deposited under
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title description 21
- 239000000203 mixture Substances 0.000 claims abstract description 148
- 230000000694 effects Effects 0.000 claims abstract description 95
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 82
- 238000000034 method Methods 0.000 claims abstract description 39
- 238000011534 incubation Methods 0.000 claims abstract description 22
- 102000004157 Hydrolases Human genes 0.000 claims abstract description 17
- 108090000604 Hydrolases Proteins 0.000 claims abstract description 17
- 235000008939 whole milk Nutrition 0.000 claims abstract description 16
- 230000002829 reductive effect Effects 0.000 claims abstract description 9
- 102000004190 Enzymes Human genes 0.000 claims description 48
- 108090000790 Enzymes Proteins 0.000 claims description 48
- 229940088598 enzyme Drugs 0.000 claims description 48
- 238000009472 formulation Methods 0.000 claims description 48
- 238000004140 cleaning Methods 0.000 claims description 47
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 43
- 239000003599 detergent Substances 0.000 claims description 35
- 244000005700 microbiome Species 0.000 claims description 32
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 26
- 239000004094 surface-active agent Substances 0.000 claims description 24
- 102000013142 Amylases Human genes 0.000 claims description 22
- 108010065511 Amylases Proteins 0.000 claims description 22
- 235000019418 amylase Nutrition 0.000 claims description 22
- 108091005804 Peptidases Proteins 0.000 claims description 21
- 239000004382 Amylase Substances 0.000 claims description 18
- 239000004365 Protease Substances 0.000 claims description 18
- 241000563903 Bacillus velezensis Species 0.000 claims description 17
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 15
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 15
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 15
- 108010059892 Cellulase Proteins 0.000 claims description 14
- 244000063299 Bacillus subtilis Species 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 12
- 239000003755 preservative agent Substances 0.000 claims description 11
- 229940106157 cellulase Drugs 0.000 claims description 10
- 235000019626 lipase activity Nutrition 0.000 claims description 7
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- -1 Methylphenylglycol Chemical compound 0.000 description 48
- 239000002253 acid Substances 0.000 description 39
- 235000013336 milk Nutrition 0.000 description 38
- 239000008267 milk Substances 0.000 description 38
- 210000004080 milk Anatomy 0.000 description 38
- 230000001580 bacterial effect Effects 0.000 description 33
- 125000000217 alkyl group Chemical group 0.000 description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 24
- 239000007788 liquid Substances 0.000 description 22
- 239000000047 product Substances 0.000 description 22
- 150000007513 acids Chemical class 0.000 description 21
- 239000000523 sample Substances 0.000 description 21
- 102000035195 Peptidases Human genes 0.000 description 20
- 235000014113 dietary fatty acids Nutrition 0.000 description 19
- 229930195729 fatty acid Natural products 0.000 description 19
- 239000000194 fatty acid Substances 0.000 description 19
- 229920000642 polymer Polymers 0.000 description 19
- 235000000346 sugar Nutrition 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 229920001817 Agar Polymers 0.000 description 18
- 239000008272 agar Substances 0.000 description 18
- 229940023476 agar Drugs 0.000 description 18
- 150000001768 cations Chemical class 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 17
- 239000003352 sequestering agent Substances 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 16
- 150000003839 salts Chemical class 0.000 description 16
- 108090001060 Lipase Proteins 0.000 description 15
- 238000003556 assay Methods 0.000 description 15
- 238000000855 fermentation Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 239000000758 substrate Substances 0.000 description 15
- 102000004882 Lipase Human genes 0.000 description 14
- 108090000637 alpha-Amylases Proteins 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 14
- 235000019419 proteases Nutrition 0.000 description 14
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical compound OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 14
- 239000004367 Lipase Substances 0.000 description 13
- 230000004151 fermentation Effects 0.000 description 13
- 235000019421 lipase Nutrition 0.000 description 13
- 239000002736 nonionic surfactant Substances 0.000 description 13
- 239000002773 nucleotide Substances 0.000 description 13
- 125000003729 nucleotide group Chemical group 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- 229920001577 copolymer Polymers 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 229920002125 Sokalan® Polymers 0.000 description 11
- 102000004139 alpha-Amylases Human genes 0.000 description 11
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 10
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- 230000007774 longterm Effects 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 229940024171 alpha-amylase Drugs 0.000 description 9
- 125000000129 anionic group Chemical group 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 239000008101 lactose Substances 0.000 description 9
- 239000002689 soil Substances 0.000 description 9
- 239000002562 thickening agent Substances 0.000 description 9
- 150000001298 alcohols Chemical class 0.000 description 8
- 125000003342 alkenyl group Chemical group 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 7
- 108090000787 Subtilisin Proteins 0.000 description 7
- 150000001412 amines Chemical class 0.000 description 7
- 239000003945 anionic surfactant Substances 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 229920000057 Mannan Polymers 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 239000007844 bleaching agent Substances 0.000 description 6
- 125000002843 carboxylic acid group Chemical group 0.000 description 6
- 239000002738 chelating agent Substances 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 108010005400 cutinase Proteins 0.000 description 6
- 230000000593 degrading effect Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 229960005323 phenoxyethanol Drugs 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- 150000003628 tricarboxylic acids Chemical class 0.000 description 6
- 230000035899 viability Effects 0.000 description 6
- 108020004635 Complementary DNA Proteins 0.000 description 5
- 102000004316 Oxidoreductases Human genes 0.000 description 5
- 108090000854 Oxidoreductases Proteins 0.000 description 5
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- 150000001340 alkali metals Chemical class 0.000 description 5
- 229940025131 amylases Drugs 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 230000001461 cytolytic effect Effects 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 150000002191 fatty alcohols Chemical class 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229920001519 homopolymer Polymers 0.000 description 5
- 230000002366 lipolytic effect Effects 0.000 description 5
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 5
- 239000011976 maleic acid Substances 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 239000003002 pH adjusting agent Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 150000003138 primary alcohols Chemical class 0.000 description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 5
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 4
- CIEZZGWIJBXOTE-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)C(C)N(CC(O)=O)CC(O)=O CIEZZGWIJBXOTE-UHFFFAOYSA-N 0.000 description 4
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 4
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 4
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 229920002670 Fructan Polymers 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 241000588287 Paenibacillus glycanilyticus Species 0.000 description 4
- 102000012479 Serine Proteases Human genes 0.000 description 4
- 108010022999 Serine Proteases Proteins 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 125000005233 alkylalcohol group Chemical group 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 150000003863 ammonium salts Chemical class 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 4
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000008447 perception Effects 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 230000028070 sporulation Effects 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 239000003760 tallow Substances 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- BZANQLIRVMZFOS-ZKZCYXTQSA-N (3r,4s,5s,6r)-2-butoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BZANQLIRVMZFOS-ZKZCYXTQSA-N 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- 241000203069 Archaea Species 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- 102000005575 Cellulases Human genes 0.000 description 3
- 108010084185 Cellulases Proteins 0.000 description 3
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 3
- 240000008886 Ceratonia siliqua Species 0.000 description 3
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- 108090000371 Esterases Proteins 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241001387977 Gulosibacter Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 3
- 101710163270 Nuclease Proteins 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 241000193411 Paenibacillus amylolyticus Species 0.000 description 3
- 241000592795 Paenibacillus sp. Species 0.000 description 3
- 108010067372 Pancreatic elastase Proteins 0.000 description 3
- 102000016387 Pancreatic elastase Human genes 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 125000002947 alkylene group Chemical group 0.000 description 3
- 108010028144 alpha-Glucosidases Proteins 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 150000001414 amino alcohols Chemical class 0.000 description 3
- 239000002518 antifoaming agent Substances 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 229960004365 benzoic acid Drugs 0.000 description 3
- 108010047754 beta-Glucosidase Proteins 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 150000002009 diols Chemical class 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000001952 enzyme assay Methods 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- OUDSFQBUEBFSPS-UHFFFAOYSA-N ethylenediaminetriacetic acid Chemical compound OC(=O)CNCCN(CC(O)=O)CC(O)=O OUDSFQBUEBFSPS-UHFFFAOYSA-N 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 229940013688 formic acid Drugs 0.000 description 3
- 229960000587 glutaral Drugs 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 150000002584 ketoses Chemical group 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- YLQLIQIAXYRMDL-UHFFFAOYSA-N propylheptyl alcohol Chemical compound CCCCCC(CO)CCC YLQLIQIAXYRMDL-UHFFFAOYSA-N 0.000 description 3
- 235000019833 protease Nutrition 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 150000004760 silicates Chemical class 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 235000010199 sorbic acid Nutrition 0.000 description 3
- 239000004334 sorbic acid Substances 0.000 description 3
- 229940075582 sorbic acid Drugs 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 230000037351 starvation Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 229920001897 terpolymer Polymers 0.000 description 3
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 2
- UDQMXYJSNNCRAS-UHFFFAOYSA-N 2,3-dichlorophenylpiperazine Chemical compound ClC1=CC=CC(N2CCNCC2)=C1Cl UDQMXYJSNNCRAS-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- SZHQPBJEOCHCKM-UHFFFAOYSA-N 2-phosphonobutane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CCC(P(O)(O)=O)(C(O)=O)CC(O)=O SZHQPBJEOCHCKM-UHFFFAOYSA-N 0.000 description 2
- AOWJVNTZMBKLQO-UHFFFAOYSA-N 2-propan-2-ylheptan-1-ol Chemical compound CCCCCC(CO)C(C)C AOWJVNTZMBKLQO-UHFFFAOYSA-N 0.000 description 2
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 241001032451 Bacillus indicus Species 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 102100035687 Bile salt-activated lipase Human genes 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 2
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 208000007976 Ketosis Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 108091005461 Nucleic proteins Proteins 0.000 description 2
- 239000004435 Oxo alcohol Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 2
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920000805 Polyaspartic acid Polymers 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 2
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 150000001323 aldoses Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 229910000323 aluminium silicate Inorganic materials 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 238000000339 bright-field microscopy Methods 0.000 description 2
- 229960003168 bronopol Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 108010089934 carbohydrase Proteins 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- BYNQFCJOHGOKSS-UHFFFAOYSA-N diclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1 BYNQFCJOHGOKSS-UHFFFAOYSA-N 0.000 description 2
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 2
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical group CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 2
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- HSEMFIZWXHQJAE-UHFFFAOYSA-N hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(N)=O HSEMFIZWXHQJAE-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 229940056960 melamin Drugs 0.000 description 2
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910021527 natrosilite Inorganic materials 0.000 description 2
- LYRFLYHAGKPMFH-UHFFFAOYSA-N octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(N)=O LYRFLYHAGKPMFH-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003009 phosphonic acids Chemical class 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229910052615 phyllosilicate Inorganic materials 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920005646 polycarboxylate Polymers 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical class [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical class [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 229960001407 sodium bicarbonate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- RTVVXRKGQRRXFJ-UHFFFAOYSA-N sodium;2-sulfobutanedioic acid Chemical compound [Na].OC(=O)CC(C(O)=O)S(O)(=O)=O RTVVXRKGQRRXFJ-UHFFFAOYSA-N 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 230000004763 spore germination Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- NQHGWZGJBPOWKN-QOKIMYEXSA-N (2r,3r,4r,5r)-2,3,5,6-tetrahydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanamide Chemical compound NC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NQHGWZGJBPOWKN-QOKIMYEXSA-N 0.000 description 1
- DRFLKRMRQZUIKE-FMLOXDBGSA-N (2r,3s,4r,5r)-2,3,4,5-tetrahydroxy-6-[(9z,12z)-octadeca-9,12-dienoxy]hexanal Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCOC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O DRFLKRMRQZUIKE-FMLOXDBGSA-N 0.000 description 1
- MUQNBLPWDIVCHW-QWTFSKLTSA-N (2r,3s,4r,5r)-2,3,4,5-tetrahydroxy-6-[(z)-octadec-9-enoxy]hexanal Chemical compound CCCCCCCC\C=C/CCCCCCCCOC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O MUQNBLPWDIVCHW-QWTFSKLTSA-N 0.000 description 1
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 description 1
- GGAUUQHSCNMCAU-ZXZARUISSA-N (2s,3r)-butane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C[C@H](C(O)=O)[C@H](C(O)=O)CC(O)=O GGAUUQHSCNMCAU-ZXZARUISSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000006755 (C2-C20) alkyl group Chemical group 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- CEGRHPCDLKAHJD-UHFFFAOYSA-N 1,1,1-propanetricarboxylic acid Chemical compound CCC(C(O)=O)(C(O)=O)C(O)=O CEGRHPCDLKAHJD-UHFFFAOYSA-N 0.000 description 1
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-M 1,1-dioxo-1,2-benzothiazol-3-olate Chemical compound C1=CC=C2C([O-])=NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-M 0.000 description 1
- BPSYZMLXRKCSJY-UHFFFAOYSA-N 1,3,2-dioxaphosphepan-2-ium 2-oxide Chemical compound O=[P+]1OCCCCO1 BPSYZMLXRKCSJY-UHFFFAOYSA-N 0.000 description 1
- 150000000185 1,3-diols Chemical class 0.000 description 1
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- OAAZUWWNSYWWHG-UHFFFAOYSA-N 1-phenoxypropan-1-ol Chemical compound CCC(O)OC1=CC=CC=C1 OAAZUWWNSYWWHG-UHFFFAOYSA-N 0.000 description 1
- FENFUOGYJVOCRY-UHFFFAOYSA-N 1-propoxypropan-2-ol Chemical compound CCCOCC(C)O FENFUOGYJVOCRY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HWGJWYNMDPTGTD-UHFFFAOYSA-N 1h-azonine Chemical compound C=1C=CC=CNC=CC=1 HWGJWYNMDPTGTD-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- PQHYOGIRXOKOEJ-UHFFFAOYSA-N 2-(1,2-dicarboxyethylamino)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)NC(C(O)=O)CC(O)=O PQHYOGIRXOKOEJ-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 1
- DMQQXDPCRUGSQB-UHFFFAOYSA-N 2-[3-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CCCN(CC(O)=O)CC(O)=O DMQQXDPCRUGSQB-UHFFFAOYSA-N 0.000 description 1
- KWIPUXXIFQQMKN-UHFFFAOYSA-N 2-azaniumyl-3-(4-cyanophenyl)propanoate Chemical class OC(=O)C(N)CC1=CC=C(C#N)C=C1 KWIPUXXIFQQMKN-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- LUYIHWDYPAZCNN-UHFFFAOYSA-N 2-butyl-1,2-benzothiazol-3-one Chemical compound C1=CC=C2C(=O)N(CCCC)SC2=C1 LUYIHWDYPAZCNN-UHFFFAOYSA-N 0.000 description 1
- XMVBHZBLHNOQON-UHFFFAOYSA-N 2-butyl-1-octanol Chemical compound CCCCCCC(CO)CCCC XMVBHZBLHNOQON-UHFFFAOYSA-N 0.000 description 1
- WGPVWXXJNUNBNB-UHFFFAOYSA-N 2-carboxyphenolate;2-hydroxyethylazanium Chemical class NCCO.OC(=O)C1=CC=CC=C1O WGPVWXXJNUNBNB-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 1
- WDMUXYQIMRDWRC-UHFFFAOYSA-N 2-hydroxy-3,4-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1O WDMUXYQIMRDWRC-UHFFFAOYSA-N 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- PSZAEHPBBUYICS-UHFFFAOYSA-N 2-methylidenepropanedioic acid Chemical compound OC(=O)C(=C)C(O)=O PSZAEHPBBUYICS-UHFFFAOYSA-N 0.000 description 1
- DHMRGSATSWRQFT-UHFFFAOYSA-N 2-pentylnonan-1-ol Chemical compound CCCCCCCC(CO)CCCCC DHMRGSATSWRQFT-UHFFFAOYSA-N 0.000 description 1
- KDTZBYPBMTXCSO-UHFFFAOYSA-N 2-phenoxyphenol Chemical compound OC1=CC=CC=C1OC1=CC=CC=C1 KDTZBYPBMTXCSO-UHFFFAOYSA-N 0.000 description 1
- ONPJWQSDZCGSQM-UHFFFAOYSA-N 2-phenylprop-2-enoic acid Chemical compound OC(=O)C(=C)C1=CC=CC=C1 ONPJWQSDZCGSQM-UHFFFAOYSA-N 0.000 description 1
- YLTUHDKNZIVIJL-UHFFFAOYSA-N 2-phosphanylbutane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CCC(P)(C(O)=O)CC(O)=O YLTUHDKNZIVIJL-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- IWTIBPIVCKUAHK-UHFFFAOYSA-N 3-[bis(2-carboxyethyl)amino]propanoic acid Chemical compound OC(=O)CCN(CCC(O)=O)CCC(O)=O IWTIBPIVCKUAHK-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- NTKBNCABAMQDIG-UHFFFAOYSA-N 3-butoxypropan-1-ol Chemical compound CCCCOCCCO NTKBNCABAMQDIG-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- JKTORXLUQLQJCM-UHFFFAOYSA-N 4-phosphonobutylphosphonic acid Chemical compound OP(O)(=O)CCCCP(O)(O)=O JKTORXLUQLQJCM-UHFFFAOYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 102000001741 Acid Anhydride Hydrolases Human genes 0.000 description 1
- 108010054645 Acid Anhydride Hydrolases Proteins 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 241001143270 Alkalicoccus saliphilus Species 0.000 description 1
- 241000916411 Alteribacillus persepolensis Species 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108010024976 Asparaginase Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241001260372 Bacillus acidicola Species 0.000 description 1
- 241001150382 Bacillus aerius Species 0.000 description 1
- 241001150378 Bacillus aerophilus Species 0.000 description 1
- 241000513399 Bacillus aidingensis Species 0.000 description 1
- 241000193376 Bacillus akibai Species 0.000 description 1
- 241000193375 Bacillus alcalophilus Species 0.000 description 1
- 241000285020 Bacillus algicola Species 0.000 description 1
- 241000287345 Bacillus alkalisediminis Species 0.000 description 1
- 241000496456 Bacillus alveayuensis Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241001143891 Bacillus aquimaris Species 0.000 description 1
- 241000331867 Bacillus asahii Species 0.000 description 1
- 241000193410 Bacillus atrophaeus Species 0.000 description 1
- 241001363720 Bacillus aurantiacus Species 0.000 description 1
- 241000193409 Bacillus azotoformans Species 0.000 description 1
- 241000193408 Bacillus badius Species 0.000 description 1
- 241001113888 Bacillus beveridgei Species 0.000 description 1
- 241001026324 Bacillus bogoriensis Species 0.000 description 1
- 241000347655 Bacillus canaveralius Species 0.000 description 1
- 241000006380 Bacillus carboniphilus Species 0.000 description 1
- 241000845425 Bacillus cecembensis Species 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 241000365704 Bacillus decolorationis Species 0.000 description 1
- 241001364843 Bacillus farraginis Species 0.000 description 1
- 241000006381 Bacillus flexus Species 0.000 description 1
- 241001364845 Bacillus fordii Species 0.000 description 1
- 241000977264 Bacillus funiculus Species 0.000 description 1
- 241001385703 Bacillus galliciensis Species 0.000 description 1
- 241001328119 Bacillus gibsonii Species 0.000 description 1
- 241001328135 Bacillus halmapalus Species 0.000 description 1
- 241000006382 Bacillus halodurans Species 0.000 description 1
- 241000602818 Bacillus hemicellulosilyticus Species 0.000 description 1
- 241001301836 Bacillus horti Species 0.000 description 1
- 241001245216 Bacillus hwajinpoensis Species 0.000 description 1
- 241001661600 Bacillus idriensis Species 0.000 description 1
- 241001661602 Bacillus infantis Species 0.000 description 1
- 241000038661 Bacillus isabeliae Species 0.000 description 1
- 241000756349 Bacillus korlensis Species 0.000 description 1
- 241001092457 Bacillus kribbensis Species 0.000 description 1
- 241001523399 Bacillus krulwichiae Species 0.000 description 1
- 241000867095 Bacillus lehensis Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241001143890 Bacillus marisflavi Species 0.000 description 1
- 241001249117 Bacillus mojavensis Species 0.000 description 1
- 241001662157 Bacillus niabensis Species 0.000 description 1
- 241000223014 Bacillus novalis Species 0.000 description 1
- 241000344824 Bacillus okhensis Species 0.000 description 1
- 241001536371 Bacillus oleronius Species 0.000 description 1
- 241001120919 Bacillus oshimensis Species 0.000 description 1
- 241001429228 Bacillus pocheonensis Species 0.000 description 1
- 241000906059 Bacillus pseudomycoides Species 0.000 description 1
- 241000194104 Bacillus psychrosaccharolyticus Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 241000835167 Bacillus safensis Species 0.000 description 1
- 241000560147 Bacillus selenatarsenatis Species 0.000 description 1
- 241000798847 Bacillus seohaeanensis Species 0.000 description 1
- 241000278457 Bacillus siamensis Species 0.000 description 1
- 241000193400 Bacillus simplex Species 0.000 description 1
- 241001302493 Bacillus siralis Species 0.000 description 1
- 241000193399 Bacillus smithii Species 0.000 description 1
- 241000315694 Bacillus tequilensis Species 0.000 description 1
- 241001495667 Bacillus thermoamylovorans Species 0.000 description 1
- 241001336886 Bacillus thermolactis Species 0.000 description 1
- 241000102674 Bacillus thioparans Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241001249119 Bacillus vallismortis Species 0.000 description 1
- 241001626895 Bacillus vietnamensis Species 0.000 description 1
- 241000223012 Bacillus vireti Species 0.000 description 1
- 241000602824 Bacillus wakoensis Species 0.000 description 1
- 108700038091 Beta-glucanases Proteins 0.000 description 1
- 241001378080 Bhargavaea beijingensis Species 0.000 description 1
- 241000726107 Blastocystis hominis Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000134846 Bursaphelenchus tusciae Species 0.000 description 1
- 101100048447 Caenorhabditis elegans unc-4 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108010051152 Carboxylesterase Proteins 0.000 description 1
- 102000013392 Carboxylesterase Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 241000255930 Chironomidae Species 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- RZXLPPRPEOUENN-UHFFFAOYSA-N Chlorfenson Chemical compound C1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=C(Cl)C=C1 RZXLPPRPEOUENN-UHFFFAOYSA-N 0.000 description 1
- RKWGIWYCVPQPMF-UHFFFAOYSA-N Chloropropamide Chemical compound CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 RKWGIWYCVPQPMF-UHFFFAOYSA-N 0.000 description 1
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
- 102100023335 Chymotrypsin-like elastase family member 2A Human genes 0.000 description 1
- 102100039501 Chymotrypsinogen B Human genes 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102100024133 Coiled-coil domain-containing protein 50 Human genes 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 108020001738 DNA Glycosylase Proteins 0.000 description 1
- 102000028381 DNA glycosylase Human genes 0.000 description 1
- 239000004375 Dextrin Chemical class 0.000 description 1
- 229920001353 Dextrin Chemical class 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 244000101366 Diplotaxis muralis Species 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N E-Sorbic acid Chemical compound C\C=C\C=C\C(O)=O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- 108700034212 EC 3.4.21.118 Proteins 0.000 description 1
- 108700034182 EC 3.4.21.119 Proteins 0.000 description 1
- 108700036029 EC 3.4.21.35 Proteins 0.000 description 1
- 108700036045 EC 3.4.21.78 Proteins 0.000 description 1
- 108700036044 EC 3.4.21.79 Proteins 0.000 description 1
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 description 1
- 101710111935 Endo-beta-1,4-glucanase Proteins 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241001376287 Fictibacillus arsenicus Species 0.000 description 1
- 241001024488 Fictibacillus macauensis Species 0.000 description 1
- 241000845813 Fictibacillus solisalsi Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
- 108091006109 GTPases Proteins 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229930187199 Graminin Natural products 0.000 description 1
- 102000001398 Granzyme Human genes 0.000 description 1
- 108060005986 Granzyme Proteins 0.000 description 1
- 102100030386 Granzyme A Human genes 0.000 description 1
- 102100030385 Granzyme B Human genes 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000033197 Hemibarbus labeo Species 0.000 description 1
- 102100031415 Hepatic triacylglycerol lipase Human genes 0.000 description 1
- 101000910772 Homo sapiens Coiled-coil domain-containing protein 50 Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 108050009363 Hyaluronidases Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 102000001399 Kallikrein Human genes 0.000 description 1
- 108060005987 Kallikrein Proteins 0.000 description 1
- 102100038297 Kallikrein-1 Human genes 0.000 description 1
- 102100034870 Kallikrein-8 Human genes 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001167717 Lysinibacillus odysseyi Species 0.000 description 1
- MQHWFIOJQSCFNM-UHFFFAOYSA-L Magnesium salicylate Chemical class [Mg+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O MQHWFIOJQSCFNM-UHFFFAOYSA-L 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 102000010722 N-Glycosyl Hydrolases Human genes 0.000 description 1
- 108010063372 N-Glycosyl Hydrolases Proteins 0.000 description 1
- YKHCUPXZINPHEB-UHFFFAOYSA-N NCCO.OP(=O)OP(O)=O Chemical compound NCCO.OP(=O)OP(O)=O YKHCUPXZINPHEB-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 102100033174 Neutrophil elastase Human genes 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241001238056 Paraburkholderia ginsengisoli Species 0.000 description 1
- 241000861159 Paraburkholderia ginsengiterrae Species 0.000 description 1
- 241000866630 Paraburkholderia graminis Species 0.000 description 1
- 241000480193 Paraburkholderia soli Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 102000003827 Plasma Kallikrein Human genes 0.000 description 1
- 108090000113 Plasma Kallikrein Proteins 0.000 description 1
- 102100038124 Plasminogen Human genes 0.000 description 1
- 229920002257 Plurafac® Polymers 0.000 description 1
- 229920002218 Plurafac® CS-10 Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 101710194948 Protein phosphatase PhpP Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 101000945873 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Lipid droplet hydrolase 1 Proteins 0.000 description 1
- 241001023238 Salibacterium halochares Species 0.000 description 1
- 241000105345 Salibacterium qingdaonense Species 0.000 description 1
- 241000747359 Salipaludibacillus neizhouensis Species 0.000 description 1
- 241000894029 Salisediminibacterium locisalis Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical class [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 241000976732 Solibacillus isronensis Species 0.000 description 1
- 108010055297 Sterol Esterase Proteins 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- LINDOXZENKYESA-UHFFFAOYSA-N TMG Natural products CNC(N)=NC LINDOXZENKYESA-UHFFFAOYSA-N 0.000 description 1
- 229920013806 TRITON CG-110 Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108060008539 Transglutaminase Proteins 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- HEGOZZGDTGYRGM-OIMNJJJWSA-N [(2r,3r,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexyl] octanoate Chemical compound CCCCCCCC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O HEGOZZGDTGYRGM-OIMNJJJWSA-N 0.000 description 1
- KGUHOFWIXKIURA-VQXBOQCVSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dodecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCC)O[C@@H]1O[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H](CO)O1 KGUHOFWIXKIURA-VQXBOQCVSA-N 0.000 description 1
- YAWYUSRBDMEKHZ-UHFFFAOYSA-N [2-hydroxyethyl(phosphonomethyl)amino]methylphosphonic acid Chemical compound OCCN(CP(O)(O)=O)CP(O)(O)=O YAWYUSRBDMEKHZ-UHFFFAOYSA-N 0.000 description 1
- 241001327213 [Bacillus] clarkii Species 0.000 description 1
- 241001468250 [Bacillus] thermocloacae Species 0.000 description 1
- 241001517045 [Bacillus] vedderi Species 0.000 description 1
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 1
- KVUUQMDVROTSNI-UHFFFAOYSA-N [morpholin-4-yl(phosphono)methyl]phosphonic acid Chemical compound OP(O)(=O)C(P(O)(O)=O)N1CCOCC1 KVUUQMDVROTSNI-UHFFFAOYSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 108010058834 acylcarnitine hydrolase Proteins 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 125000005741 alkyl alkenyl group Chemical group 0.000 description 1
- 125000005466 alkylenyl group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 229940090948 ammonium benzoate Drugs 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 229940098323 ammonium cocoyl isethionate Drugs 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960003272 asparaginase Drugs 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OCSIXPGPUXCISD-UHFFFAOYSA-N azane;2-[dodecanoyl(methyl)amino]acetic acid Chemical compound N.CCCCCCCCCCCC(=O)N(C)CC(O)=O OCSIXPGPUXCISD-UHFFFAOYSA-N 0.000 description 1
- ZXVOCOLRQJZVBW-UHFFFAOYSA-N azane;ethanol Chemical compound N.CCO ZXVOCOLRQJZVBW-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 229960002233 benzalkonium bromide Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical class CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical class [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical class [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- MRNZSTMRDWRNNR-UHFFFAOYSA-N bis(hexamethylene)triamine Chemical compound NCCCCCCNCCCCCCN MRNZSTMRDWRNNR-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- PVEOYINWKBTPIZ-UHFFFAOYSA-N but-3-enoic acid Chemical compound OC(=O)CC=C PVEOYINWKBTPIZ-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000004301 calcium benzoate Chemical class 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 1
- 235000010244 calcium sorbate Nutrition 0.000 description 1
- 239000004303 calcium sorbate Substances 0.000 description 1
- AVVIDTZRJBSXML-UHFFFAOYSA-L calcium;2-carboxyphenolate;dihydrate Chemical class O.O.[Ca+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O AVVIDTZRJBSXML-UHFFFAOYSA-L 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical class O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 108010085318 carboxymethylcellulase Proteins 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000014651 chocolate spreads Nutrition 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 229940096386 coconut alcohol Drugs 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 235000015146 crème fraîche Nutrition 0.000 description 1
- 235000015142 cultured sour cream Nutrition 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- STZIXLPVKZUAMV-UHFFFAOYSA-N cyclopentane-1,1,2,2-tetracarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCCC1(C(O)=O)C(O)=O STZIXLPVKZUAMV-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- TUTWLYPCGCUWQI-UHFFFAOYSA-N decanamide Chemical compound CCCCCCCCCC(N)=O TUTWLYPCGCUWQI-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- SHLKYEAQGUCTIO-UHFFFAOYSA-N diazanium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [NH4+].[NH4+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O SHLKYEAQGUCTIO-UHFFFAOYSA-N 0.000 description 1
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- GYQQNCSTNDNVMM-UHFFFAOYSA-L disodium 4-(octadecylamino)-4-oxo-2-sulfobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCCNC(=O)CC(C([O-])=O)S(O)(=O)=O.CCCCCCCCCCCCCCCCCCNC(=O)CC(C([O-])=O)S(O)(=O)=O GYQQNCSTNDNVMM-UHFFFAOYSA-L 0.000 description 1
- MCPLVIGCWWTHFH-UHFFFAOYSA-M disodium;4-[4-[[4-(4-sulfoanilino)phenyl]-[4-(4-sulfonatophenyl)azaniumylidenecyclohexa-2,5-dien-1-ylidene]methyl]anilino]benzenesulfonate Chemical group [Na+].[Na+].C1=CC(S(=O)(=O)O)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[NH+]C=2C=CC(=CC=2)S([O-])(=O)=O)C=2C=CC(NC=3C=CC(=CC=3)S([O-])(=O)=O)=CC=2)C=C1 MCPLVIGCWWTHFH-UHFFFAOYSA-M 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 108010050200 endo-1,4-beta-D-mannanase Proteins 0.000 description 1
- 108010091371 endoglucanase 1 Proteins 0.000 description 1
- 108010091384 endoglucanase 2 Proteins 0.000 description 1
- 108010092450 endoglucanase Z Proteins 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002193 fatty amides Chemical class 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 150000002454 idoses Chemical class 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- VRWKTAYJTKRVCU-UHFFFAOYSA-N iron(6+);hexacyanide Chemical compound [Fe+6].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] VRWKTAYJTKRVCU-UHFFFAOYSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000015141 kefir Nutrition 0.000 description 1
- 108010059345 keratinase Proteins 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 150000002596 lactones Chemical group 0.000 description 1
- 235000020190 lactose-free milk Nutrition 0.000 description 1
- 229940116335 lauramide Drugs 0.000 description 1
- 229940048866 lauramine oxide Drugs 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 108010062085 ligninase Proteins 0.000 description 1
- 125000005645 linoleyl group Chemical group 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- PJJZFXPJNUVBMR-UHFFFAOYSA-L magnesium benzoate Chemical class [Mg+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 PJJZFXPJNUVBMR-UHFFFAOYSA-L 0.000 description 1
- 229940072082 magnesium salicylate Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 150000005673 monoalkenes Chemical group 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- NYNKJVPRTLBJNQ-UHFFFAOYSA-N n'-(3-aminopropyl)-n'-dodecylpropane-1,3-diamine Chemical compound CCCCCCCCCCCCN(CCCN)CCCN NYNKJVPRTLBJNQ-UHFFFAOYSA-N 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- JPMIIZHYYWMHDT-UHFFFAOYSA-N octhilinone Chemical compound CCCCCCCCN1SC=CC1=O JPMIIZHYYWMHDT-UHFFFAOYSA-N 0.000 description 1
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- FATBGEAMYMYZAF-UHFFFAOYSA-N oleicacidamide-heptaglycolether Natural products CCCCCCCCC=CCCCCCCCC(N)=O FATBGEAMYMYZAF-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- LVZSQWIWCANHPF-UHFFFAOYSA-N p-nitrophenyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC1=CC=C([N+]([O-])=O)C=C1 LVZSQWIWCANHPF-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000155 pancreatic elastase II Proteins 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000020200 pasteurised milk Nutrition 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 108010087558 pectate lyase Proteins 0.000 description 1
- 239000001814 pectin Chemical class 0.000 description 1
- 229920001277 pectin Chemical class 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical class NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- FRMWBRPWYBNAFB-UHFFFAOYSA-M potassium salicylate Chemical class [K+].OC1=CC=CC=C1C([O-])=O FRMWBRPWYBNAFB-UHFFFAOYSA-M 0.000 description 1
- 229960003629 potassium salicylate Drugs 0.000 description 1
- CHHHXKFHOYLYRE-STWYSWDKSA-M potassium sorbate Chemical compound [K+].C\C=C\C=C\C([O-])=O CHHHXKFHOYLYRE-STWYSWDKSA-M 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000006254 rheological additive Substances 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000004708 ribosome subunit Anatomy 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229940045998 sodium isethionate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940045944 sodium lauroyl glutamate Drugs 0.000 description 1
- 229940048106 sodium lauroyl isethionate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- BRMSVEGRHOZCAM-UHFFFAOYSA-M sodium;2-dodecanoyloxyethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OCCS([O-])(=O)=O BRMSVEGRHOZCAM-UHFFFAOYSA-M 0.000 description 1
- LADXKQRVAFSPTR-UHFFFAOYSA-M sodium;2-hydroxyethanesulfonate Chemical compound [Na+].OCCS([O-])(=O)=O LADXKQRVAFSPTR-UHFFFAOYSA-M 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 229940037312 stearamide Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 229940032085 sucrose monolaurate Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 108010038851 tannase Proteins 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- UZVUJVFQFNHRSY-OUTKXMMCSA-J tetrasodium;(2s)-2-[bis(carboxylatomethyl)amino]pentanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC[C@@H](C([O-])=O)N(CC([O-])=O)CC([O-])=O UZVUJVFQFNHRSY-OUTKXMMCSA-J 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 102000003601 transglutaminase Human genes 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical class OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000001974 tryptic soy broth Substances 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000005065 undecenyl group Chemical group C(=CCCCCCCCCC)* 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
- 108010062040 wax-ester hydrolase Proteins 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C3/00—Preservation of milk or milk preparations
- A23C3/08—Preservation of milk or milk preparations by addition of preservatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0068—Deodorant compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/381—Microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
Definitions
- new Bacillus strains are provided. More specifically, Bacillus strains having extracellular hydrolase activity and demonstrating reduced malodor after incubation for at least 5 days for at least 25 °C in a lactose-free whole milk sample compared to a noninoculated lactose-free whole milk sample, a composition comprising these strains and methods using the new Bacillus strains are provided.
- Microorganisms generally live attached to surfaces in many natural, industrial, and medical environments, encapsulated by extracellular substances including biopolymers and macromolecules. Exposed to suitable conditions these microorganisms can grow and effect malodor caused by their own metabolites or by forming biofilms that provide a sticky area for malodor molecules of the surroundings.
- laundry items when laundry items are used, they are contacted to sweat and microorganisms from the body of the user. Some of these microorganisms, especially bacteria, are capable of adhering to the laundry item and form a biofilm on the item. Due to the above mentioned reasons, the presence of the microorganisms causes the laundry items to smell.
- milk is an excellent growth medium for microorganisms, in particular bacteria. It provides the nutrients and moisture and has a near neutral pH.
- Off-flavors and/or malodors in milk are the results of bacterial growth, named psychrotrophs. Psychrotrophs include many kinds of bacteria, all of which cause milk spoilage. Their ideal growth temperature is 18-22° C. Cold temperatures slow their growth, but do not kill them. At 7° C or above, their growth is steady and off-flavors and/or malodors can be present within two to three days.
- WO 2011/098579 concerns bacterial deoxyribonuclease formulations and methods for biofilm disruption and prevention.
- said formulations may control bacterially caused malodors.
- the synthesis and purification of said nuclease polypeptides is time consuming and expensive.
- Bacillus strains (i) have extracellular enzyme activity, (ii) provide odor control, in particular they reduce or avoid malodors emerging in milk samples, (iii) demonstrate long term cleaning effects on hard surfaces and (iv) are able to survive in a wide pH range.
- the Bacillus strains of the present invention can be used without further ingredients or in combination with additional cleaning components to control malodors and/or to provide long term cleaning effects caused by microbial growth without the prior need of laborious and expensive protein purification.
- the Bacillus strains may be used in their sporulated forms.
- the problem underlying the present invention is solved by a Bacillus strain having extracellular hydrolase activity and demonstrating reduced malodor after incubation for at least 5 days for at least 25 °C in a lactose-free whole milk sample compared to a noninoculated lactose-free whole milk sample.
- the hydrolase activity is selected from protease activity, amylase activity, lipase activity, mannanase activity, cellulase activity or combinations thereof.
- the incubation is for at least 7 days for at least 30 °C.
- said strain has the ability to form a spore and preferably is in the form of a spore.
- the invention is also directed to preferred embodiments in which said strain is selected from the group of Bacillus species consisting of Bacillus methylotrophicus, Bacillus subtilis and Bacillus amyloliquefaciens.
- the invention is directed to a Bacillus strain of the invention i) as deposited under accession number DSM 34306 or a mutant thereof having all of the identifying characteristics as described above; ii) as deposited under accession number DSM 34307 or a mutant thereof having all of the identifying characteristics as described above; iii) as deposited under accession number DSM 34304 or a mutant thereof having all of the identifying characteristics as described above; or iv) as deposited under accession number DSM 34305 or a mutant thereof having all of the identifying characteristics as described above.
- the invention is directed to a Bacillus strain of the invention, wherein i) the strain as deposited under accession number DSM 34306 comprises 16S rDNA having the sequence of SEQ I D NO: 1 ; ii) the strain as deposited under accession number DSM 34307 comprises 16S rDNA having the sequence of SEQ ID NO:2; iii) the strain as deposited under accession number DSM 34304 comprises 16S rDNA having the sequence of SEQ ID NO:3; or iv) the strain as deposited under accession number DSM 34305 comprises 16S rDNA having the sequence of SEQ ID NO:4.
- the invention is directed to a Bacillus strain of the invention, wherein i) the mutant of the strain as deposited under accession number DSM 34306 comprises 16S rDNA having at least 98% sequence identity to SEQ ID NO:1; ii) the mutant of the strain as deposited under accession number DSM 34307 comprises 16S rDNA having at least 98% sequence identity to SEQ ID NO:2; iii) the mutant of the strain as deposited under accession number DSM 34304 comprises 16S rDNA having at least 98% sequence identity to SEQ ID NO:3; or iv) the mutant of the strain as deposited under accession number DSM 34305 comprises 16S rDNA having at least 98% sequence identity to SEQ ID NO:4.
- the present invention is directed to a composition comprising at least one Bacillus strain of the invention and at least one additional component.
- the composition is a detergent composition, more preferably a laundry detergent composition, a hard surface cleaning detergent composition, a sanitary or kitchen cleaner or an anti-malodor product.
- the composition comprises one or more surfactants and/or one or more builders and/or one or more enzymes and/or one or more preservative agents, preferably one or more surfactants and/or one or more solvents.
- the present invention is directed to a method to improve detergency of a detergent formulation by adding at least one Bacillus strain of the invention to a detergent formulation.
- the present invention is directed to a cleaning method comprising contacting at least one Bacillus strain of the invention or a composition of the invention with an object that requires cleaning, preferably a laundry or a hard surface household item.
- the present invention is directed to a method to reduce malodor comprising contacting at least one Bacillus strain of the invention or a composition of the invention with an object that requires cleaning, preferably a laundry or a hard surface household item.
- the present invention is directed to a method to control or reduce malodor- causing microorganisms comprising contacting at least one Bacillus strain of the invention or a composition of the invention with an object or with a medium on/in which said microorganisms are present or grow.
- the present invention is directed to the use of a Bacillus strain as deposited under accession number DSM 34306, DSM 34307, DSM 34304 or DSM 34305 for malodor inhibition. Brief description of the figures
- Fig. 1 shows growth and spore formation of eight test strains, namely Bacillus methylotrophicus (comprising SEQ ID NO:1), Bacillus subtilis (comprising SEQ ID NO:2), Bacillus amyloliquefaciens (comprising SEQ ID NO:3), Bacillus amyloliquefaciens (comprising SEQ ID NO:4), Paenibacillus sp., Paenibacillus glycanilyticus, Paenibacillus amylolyticus and Gulosibacter faecalis after 72 h cultivation in BA055 medium.
- Bacillus methylotrophicus comprising SEQ ID NO:1
- Bacillus subtilis comprising SEQ ID NO:2
- Bacillus amyloliquefaciens comprising SEQ ID NO:3
- Bacillus amyloliquefaciens comprising SEQ ID NO:4
- Paenibacillus sp.
- Fig. 2 shows evaluation of four different enzyme activities on agar plates for the above- mentioned bacterial strains.
- Fig. 3 shows the score values for the categories spore count, enzyme score and odor control as well as the total score for eight bacterial strains tested.
- Fig. 4 shows DM-03 (shepherd’s pie) CFT-tiles that were coated with spore formulations of the indicated strains for 7 days and 30°C without mechanical cleaning and rinsed with dH 2 O to remove soil.
- CTRL surfactant without spores or water without spores.
- Fig. 5 A shows spore viability of selected strains of the invention (Bacillus methylotrophicus (comprising SEQ ID NO:1), Bacillus subtilis (comprising SEQ ID NO:2), Bacillus amyloliquefaciens (comprising SEQ ID NO:3), Bacillus amyloliquefaciens (comprising SEQ ID NO:4)) in 60 % glycerol solutions adjusted to pH 5 (grey + clear), 7 (white + dots) and 9 (black + stripes) stored at room temperature. No significant decrease in viability was observed for any strain.
- Fig. 5 B shows a bright-field microscopy of Bacillus amyloliquefaciens (comprising SEQ ID NO:3) stored at pH 9 after 14 days (100x magnification) showing solely spores without any vegetative cells.
- Fig. 6 shows the comparison of inventive strains with reference strains via sensory malodor determination and via HPLC measurement.
- Bacillus strains offer the combination of good sporulation and spore viability, sufficient extracellular enzyme activity, for example protease, lipase, amylase and mannanase activity and having the ability to control malodors caused by microorganisms, in particular they reduce or avoid malodors emerging in milk samples.
- These new Bacillus strains can be used in (hard surface) cleaning, ADW, malodor inhibiting and detergent formulations to provide cleaning effects and to control malodors.
- these Bacillus strains are selected from the group consisting of Bacillus methylotrophicus, Bacillus subtilis and Bacillus amyloliquefaciens.
- the problem underlying the present invention is solved by a Bacillus strain having extracellular hydrolase activity and demonstrating reduced malodor after incubation for at least 5 days for at least 25 °C in a lactose-free whole milk sample compared to a noninoculated lactose-free whole milk sample.
- Bacillus and “Bacillus strain”, as interchangeably used herein, refer to a genus of Gram-positive, rod-shaped bacteria which are members of the division Firmicutes. Under stressful environmental conditions, the Bacillus bacteria produce oval endospores that can stay dormant for extended periods. Bacillus bacteria may be characterized and identified based on the nucleotide sequence of their 16S rRNA or a fragment thereof (e.g. approximately a 1000 nt, 1100 nt, 1200 nt, 1300 nt, 1400 nt, or 1500 nt fragment of 16S rRNA or rDNA nucleotide sequence).
- Bacillus comprises 266 species and may include, but is not limited to B. acicliceler, B. acidicola, B. cidiproducens, B. aeoliiis, B. aerius, B. aerophilus, B. agaradaerens, B. aidingensis, B. akibai, B. alcalophilus, B. algicola, B. alkalinilriticilis, B. alkalisediminis, B. alkalitelhtris, B. allitudinis, B. alveayuensis, B. amyloliquefaciens, B. anthracis, B. aquimaris, B.
- arsenicus B. aryabhatiai. B. asahii, B. atrophaeus, B. aurantiacus, B. azotoformans, B. badius, B. barharicus, B. baiaviensi, B. beijingensis. B. beiizoevorans, B. beveridgei, B. bogoriensis, B. boroiiiphilus, B. biiianolivoraiis, B. canaveralius, B. carboniphilus, B. cecembensis, B. cellulosilyiiciis, B. cereiis, B. chagarmorensis, B. chwigangensis, B.
- giiisengi B. giiisengihitini, B. graminis, B. halmapalus, B. halochares, B. halodurans, B. hemicellulosilyticus, B. herberlslcinensis, B. Iwrikoshi, B. Iwrneckiae, B. horti, B. hominis, B. hwajinpoensis, B. idriensis, B. indicus, B. infantis, B. infermis, B. isabeliae, B. isronensis, B. jeolgali, B. koreensis, B. korlensis, B.
- kribbensis B. krulwichiae, B. lehensis, B. lenlus, B. licheniformis, B. liloralis, B. locisalis, B. lucifereiisis, B. luleolus, B. macauensis, B. inacyae, B. mannaiiilylicus, B. marisflavi, B. marmarcnsis, B. inassilieiisis, B. inegaleiiu, B. methanolicits, B. methylotrophicus, B. mojavensis, B. muralis, B. Imirimardni, B. mycoidcs, B.
- B. iiaii/iaieiisis B. iicmhaiisedimiiiis, B. nealsoiiii, B. neizhouensis, B. niabensis, B. iiiacini, B. novalis, B. oceaiiisediminis, B. odysseyi, B. okhensis, B. okiihideiisis, B. oleronius, B. oshimensis, B. panaciterrae, B. paiagoiensis, B. persepolensis, B. plakorlidis, B. pocheonensis, B. polygon!, B.
- pseudoalcaliphilus B. pseiidofirnnis, B. pseudomycoides, B. psych rosaccharolyticus, B. pumilus, B. qingdaonensis, B. rigid, B. niris, B. safensis, B. salarhts, B. saliphilus, B. schlegelii, B. selenatarsenatis, B. selentireducens, B. seohaeanensis, B. shacklelonii, B. siamensis, B. simplex, B. siralis, B. smithii, B. soli, B. solisalsi, B. sonoreiisis, B.
- Bacillus species can be found under the following internet address and is part of this description by reference: htps://lpsn.dsmz.de/genus/bacillus.
- the invention is also directed to preferred embodiments in which said strain is selected from the group of Bacillus species consisting of Bacillus methylotrophicus, Bacillus subtilis and Bacillus amyloliquefaciens.
- strain refers to a genetic variant, a subtype or a culture within a biological species.
- the strain is naturally occurring or isolated from a natural sample, such as a soil, water, air or biological sample.
- Malodor refers to unpleasant odor directly or indirectly caused by naturally occurring bacteria and other microorganisms, such as fungi and archaea.
- a malodor is considered to be directly caused by a microorganism when the malodor is caused by one or more metabolic intermediate and/or end products of the microorganism.
- the microorganisms specifically bacteria, can form biofilms. Molecules surrounding the biofilms and having an unpleasant odor can stick to the biofilm and accumulate.
- (bacterial) biofilms can be the origin of unpleasant smell of molecules that were not synthesized by the bacteria (indirect cause of malodor).
- reduced malodor refers to a decreased amount of the unpleasant odor or its total absence.
- the malodor is reduced to at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% or at least 99% of the original malodor.
- the appearance of malodor may be measured by a smelling test or by using analytical instruments. The use of analytical instruments is preferred in cases when the chemical molecule(s) responsible for the malodor is/are known.
- malodor refers to no or an insignificant amount of butyric acid under the conditions described herein, namely incubation of the inventive strain for at least 5 days for at least 25 °C in a lactose-free whole milk sample.
- the butyric acid concentration may be below 0.2 g/L, preferably below 0.1 g/L, more preferably below 0.05 g/L and most preferred no butyric acid will be detectable using high-performance liquid chromatography (HPLC) measurement.
- HPLC high-performance liquid chromatography
- Other methods to investigate the milk sample and detect metabolites of the microorganisms, such as butyric acid are well-known to the skilled person and include, but are not limited to mass spectrometry-based methods, surface-enhanced Raman spectroscopy (SERS), nuclear magnetic resonance spectroscopy (NMR), surface plasmon resonance spectroscopy (SPRS) etc.
- the terms “incubating” and “incubation”, as used herein, refer to a process of mixing a Bacillus strain of the invention with milk and allowing them to interact under conditions defined below.
- the Bacillus strain may be in fluid form, namely a bacteria dissolved in culture medium, or in solid form as a spore or vegetive Bacillus taken from a solid culture plate.
- the incubation of the bacterial strain and the milk may occur for at least 5, at least 6 or at least 7 days.
- the incubation temperature is at least 18 °C, at least 20 °C, at least 23 °C, at least 25 °C, at least 26 °C, at least 27 °C, at least 28 °C, at least 29 °C or at least 30 °C.
- the incubation temperature may be not more than 50 °C, not more than 45 °C, not more than 40 °C, not more than 38 °C, not more than 35 °C or not more than 33 °C.
- the incubation temperature is constant.
- Preferred embodiments are directed to the incubation of the Bacillus strain of the invention and the milk for 5 days at 25-40 °C or 6 days at 25-40 °C or 7 days at 25-40 °C.
- the Bacillus strain of the invention and the milk are incubated for at least 5 days for at least 25 °C, more preferably for at least 7 days for at least 30 °C.
- the Bacillus strain of the invention and the milk are incubated for 5 days for 25 °C, more preferably for 7 days for 30 °C.
- “Noninoculated”, as used herein, means that the milk sample is not consciously brought into contact with a bacterial strain of interest those ability to reduce malodor should be tested. However, the bacteria and other microorganisms that cause milk spoilage will be found in this milk sample.
- lactose-free whole milk sample refers to milk that contains all is natural fat content. This raw milk may have a fat content of at least 3%, at least 3.5%, at least 4%, at least 4.5%, at least 5% or at least 5.5%.
- the milk may originate from a mammal, preferably a cow, goat, sheep, or buffalo, more preferably cow.
- the milk is substantially free of lactose.
- lactose-free is to be understood to include milk that comprises less than 0.20% w/w of lactose on a liquid milk basis, more specifically, less than 0.15% w/w of lactose on a liquid milk basis, even more specifically less than 0.10% w/w of lactose on a liquid milk basis, and even more specifically between 0.01%- 0.05% w/w of lactose on a liquid milk basis and even more specifically not more than 0.01% of lactose on liquid milk basis. It noted that measurements to obtain the lactose content of a milk sample may be prepared on a dry solid milk basis and subsequently are converted to a liquid milk basis. In even more preferred embodiments, the milk is not sterilized.
- (extracellular) hydrolase activity refers to the catalytic activity of a group of enzymes that use water to break a chemical bond, which typically results in dividing a larger molecule into smaller molecules.
- extracellular refers in this context to enzymatic activity that can be measured outside in the surroundings of the bacterium. This extracellular activity is caused by enzymes that the produced in the bacterium and then transported outside the bacterial cell.
- hydrolase enzymes are esterases including lipases, phosphatases, glycosidases, peptidases, and nucleosidases. Hydrolases are classified as EC 3 in the EC number classification of enzymes.
- Hydrolases can be further classified into several subclasses, based upon the bonds they act upon: EC 3.1 : ester bonds (esterases: nucleases, phosphodiesterases, lipase, phosphatase), EC 3.2: sugars (DNA glycosylases, glycoside hydrolase), EC 3.3: ether bonds, EC 3.4: peptide bonds (Proteases/peptidases), EC 3.5: carbon-nitrogen bonds, other than peptide bonds, EC 3.6 acid anhydrides (acid anhydride hydrolases, including helicases and GTPase), EC 3.7 carbon-carbon bonds, EC 3.8 halide bonds, EC 3.9: phosphorus-nitrogen bonds, EC 3.10: sulphur-nitrogen bonds, EC 3.11: carbon-phosphorus bonds, EC 3.12: sulfur-sulfur bonds and EC 3.13: carbon-sulfur bonds.
- the hydrolase activity is selected from protease activity,
- protease refers to at least one protease that may be selected from serine proteases (EC 3.4.21). Serine proteases or serine peptidases are characterized by having a serine in the catalytically active site, which forms a covalent adduct with the substrate during the catalytic reaction.
- a serine protease may be selected from the group consisting of chymotrypsin (e.g., EC 3.4.21.1), elastase (e.g., EC 3.4.21.36), elastase (e.g., EC 3.4.21.37 or EC 3.4.21.71), granzyme (e.g., EC 3.4.21.78 or EC 3.4.21.79), kallikrein (e.g., EC 3.4.21.34, EC 3.4.21.35, EC 3.4.21.118, or EC 3.4.21.119,) plasmin (e.g., EC 3.4.21.7), trypsin (e.g., EC 3.4.21.4), thrombin (e.g., EC 3.4.21.5), and subtilisin.
- chymotrypsin e.g., EC 3.4.21.1
- elastase e.g., EC 3.4.21.36
- elastase e.g
- Subtilisin is also known as subtilopeptidase, e.g., EC 3.4.21.62, the latter hereinafter also being referred to as “subtilisin’’.
- the protease exhibiting extracellular activity is a subtilisin according to EC 3.4.21.62.
- the activity of the protease may be determined on agar plates or in liquid enzyme assays.
- Assays to measure protease activity are well known in the art and can include, without being limited to colorimetric assays, mass spectrometry-based assays and fluorescence resonance energy transfer (FRET) assays.
- FRET fluorescence resonance energy transfer
- the protease assay uses milk powder as a substrate and the protease activity is at least 0.002, at least 0.005, at least 0.008, at least 0.01, at least 0.012 or at least 0.015 AU/min*mL.
- Amylases according to the invention (alpha and/or beta) include those of bacterial origin (EC 3.2.1.1 and 3.2.1.2, respectively). Preferably, amylases are selected from the group of alpha-amylases (EC 3.2.1.1). Chemically modified or protein engineered mutants are included. Amylases according to the invention have “amylolytic activity” or “amylase activity” involving (endo)hydrolysis of glucosidic linkages in polysaccharides, alpha-amylase activity may be determined by assays for measurement of alpha-amylase activity which are known to those skilled in the art.
- alphaamylase activity can be determined by a method employing Phadebas tablets as substrate (Phadebas Amylase Test, supplied by Magle Life Science). Starch is hydrolyzed by the alpha-amylase giving soluble blue fragments. The absorbance of the resulting blue solution, measured spectrophotometrically at 620 nm, is a function of the alpha-amylase activity. The measured absorbance is directly proportional to the specific activity (activity/mg of pure alpha-amylase protein) of the alpha-amylase in question under the given set of conditions.
- Alpha-amylase activity can also be determined by a method employing the Ethyliden-4- nitrophenyl-alpha-D-maltoheptaosid (EPS).
- D-maltoheptaoside is a blocked oligosaccharide which can be cleaved by an endo-amylase.
- the alpha-glucosidase included in the kit to digest the substrate to liberate a free PNP molecule which has a yellow color and thus can be measured by visible spectophotometry at 405nm.
- Kits containing EPS substrate and alpha-glucosidase is manufactured by Roche Costum Biotech (cat. No. 10880078103).
- the amylase assay uses corn starch stained with Lugolsch solution or red starch as a substrate and the amylase activity is at least 1.2, at least 1.5, at least 2.0, at least 2.5, at least 3.0, at least 3.5, at least 4.0, at least 4.5 or at least 4.7 U/rnL.
- Lipase means active protein having lipase activity (or lipolytic activity; triacylglycerol lipase, EC 3.1.1.3), cutinase activity (EC 3.1.1.74; enzymes having cutinase activity may be called cutinase herein), sterol esterase activity (EC 3.1.1.13) and/or wax-ester hydrolase activity (EC 3.1.1.50).
- Lipases include those of bacterial or fungal origin. The methods for determining lipolytic activity are well-known in the literature (see e.g. Gupta et al. (2003), Biotechnol. Appl. Biochem. 37, p. 63-71). E.g.
- Lipase activity may be measured by ester bond hydrolysis in the substrate para-nitrophenyl palmitate (pNP- Palmitate, C:16) and releases pNP which is yellow and can be detected at 405 nm.
- “Lipolytic activity” means the catalytic effect exerted by a lipase, which may be provided in lipolytic units (LU).
- the lipase assay uses tributyrin or methylumbelliferyl heptanoate as a substrate and the amylase activity is at least 48, at least 100, at least 200, at least 300, at least 400, at least 500, at least 600, at least 700 or at least 790 U/mL.
- mannanase refers to a polypeptide selected from the group of mannan degrading enzyme. At least one mannan degrading enzyme may be selected from P-mannosidase (EC 3.2.1.25), endo-1,4-p-mannosidase (EC 3.2.1.78), and 1 ,4-p- mannobiosidase (EC 3.2.1.100). Preferably, at least one mannan degrading enzyme is selected from the group of endo-1,4-p-mannosidase (EC 3.2.1.78), a group of enzymes which may be called endo-p-1 ,4-D-mannanase, p-mannanase, or mannanase herein.
- a polypeptide having mannan degrading activity or mannanase activity may be tested for according to standard test procedures known in the art, such as by applying a solution to be tested to 4 mm diameter holes punched out in agar plates containing 0.2% AZCL galactomannan (carob), i.e. substrate for the assay of endo-1 ,4-beta-D-mannanase available as CatNo. I-AZGMA from the company Megazyme (Megazyme's Internet address: http://www. megazyme. com/Purchase/index. html).
- Mannan degrading activity may alternatively be tested in a liquid assay using carob galactomannan dyed with Remazol Brilliant Bue as described in McCleary, B. V. (1978). Carbohydrate Research, 67(1), 213-221.
- Another method for testing mannan degrading activity uses detection of reducing sugars when incubated with substrate such as guar gum or locust bean gut - for reference see Miller, G. L.Use of Dinitrosalicylic Acid Reagent for Determination of Reducing Sugars. Analytical Chemistry 1959; 31: 426-428.
- the mannanase assay uses Locust Bean Gum as a substrate and the amylase activity is at least 1.2, at least 1.5, at least 2.0, at least 2.5, at least 3.0, at least 3.5, at least 4.0, at least 4.5 or at least 4.7 U/rnL.
- Cellulases “cellulase enzymes” or “cellulolytic enzymes” according to the invention are enzymes involved in hydrolysis of cellulose, i.e having “cellulolytic activity” or “cellulase activity”. At least one cellulase of the invention may be selected from cellobiohydrolase (1 ,4- P-D-glucan cellobiohydrolase, EC 3.2.1.91), endo-ss-1 ,4-glucanase (EC 3.2.1.4) and ss- glucosidase (EC 3.2.1.21).
- Endoglucanases of EC class 3.2.1.4 may be named endoglucanase, endo-1,4-ss-D-glucan 4-glucano hydrolase, endo-1,4-beta-glucanase, carboxymethyl cellulase, and beta-1, 4-glucanase.
- Assays for measurement of “cellulase activity” or “cellulolytic activity” are known to those skilled in the art. For example, cellulolytic activity may be determined by virtue of the fact that cellulase hydrolyses carboxymethyl cellulose to reducing carbohydrates, the reducing ability of which is determined colorimetrically by means of the ferricyanide reaction, according to Hoffman, W. S., J. Biol. Chem. 120, 51 (1937).
- Cellulolytic activity may be provided in units per gram enzyme. For example, 1 unit may liberate 1.0 pmole of glucose from cellulose in one hour at pH 5.0 at 37°C (2 hour incubation time). In preferred embodiments, the cellulase activity is at least 1.7, at least 3.0, at least 4.0, at least 10.0, at least 20.0, at least 25.0, at least 30.0, at least 50.0 or at least 58.0 U/rnL.
- the incubation is for at least 7 days for at least 30 °C.
- said strain has the ability form a spore and preferably is in the form of a spore.
- Bacillus cell refers to both the spore and the vegetative bacillus cell.
- spore or "bacillus spore”, as interchangeably used herein, refers to a spore which can be characterized as a resting, solid, non-reproductive structure produced by bacilli.
- the primary function of spores is, in general, to ensure the survival of bacteria during periods when external conditions become unfavorable. They are also resistant to ultraviolet radiation and gamma radiation, desiccation, lysozyme, temperature, starvation and chemical methods of exposure.
- Spores are usually found in soil and water, where they can persist for a long time.
- the spore membrane is impervious to many toxic molecules and may also contain enzymes involved in spore growth.
- the spore nucleus contains the usual cellular structures, such as DNA and ribosomes, but it is metabolically inactive. When the environment becomes unfavorable for the bacterium, it can begin the sporulation process, which takes about 8 hours. In preferred embodiments, the spore is an oval spore.
- the term “vegetative bacillus cell” refers to functional vegetative bacillus cells that can divide and produce more vegetative cells. The vegetative cells also have an active metabolism.
- the invention is directed to a Bacillus strain of the invention i) as deposited under accession number DSM 34306 or a mutant thereof having all of the identifying characteristics as described above; ii) as deposited under accession number DSM 34307 or a mutant thereof having all of the identifying characteristics as described above; iii) as deposited under accession number DSM 34304 or a mutant thereof having all of the identifying characteristics as described above; or iv) as deposited under accession number DSM 34305 or a mutant thereof having all of the identifying characteristics as described above.
- mutant refers to a mutated or deleted form of a gene or another section of the genomic sequence.
- the mutation occurs in the sequence of the 16S rDNA.
- the mutation can be associated with a functional amendment of the nucleic acid or the corresponding protein.
- the functional amendment may be a loss of function or may increase the function, e.g. the binding activity of a nucleic acid and/or protein towards another nucleic acid and/or protein.
- a mutation in the 16S rDNA may cause reduced binding of the encoded 16S rRNA molecule towards the Shine-Dalgarno sequence or towards proteins of the 30S subunit of the ribosome, such as S2-S20.
- identifying characteristics as described above refers to the characteristics of the Bacillus strain of the invention (i) to provide extracellular enzyme activity; (ii) to reduce malodor and (iii) to form a spore, all as described in more detail above.
- the invention is directed to a Bacillus strain of the invention, wherein i) the strain as deposited under accession number DSM 34306 comprises 16S rDNA having the sequence of SEQ I D NO: 1 ; ii) the strain as deposited under accession number DSM 34307 comprises 16S rDNA having the sequence of SEQ ID NO:2; iii) the strain as deposited under accession number DSM 34304 comprises 16S rDNA having the sequence of SEQ ID NO:3; or iv) the strain as deposited under accession number DSM 34305 comprises 16S rDNA having the sequence of SEQ ID NO:4.
- 16S rDNA refers to the gene encoding the 16S ribosomal RNA (16S rRNA DNA) constituted of about 1500 nucleotides, which is the main component of the small prokaryotic ribosomal subunit (30S). Also, as explained further below, the bacteria of the invention described herein may have a 16S rDNA sequence with a certain sequence identity to the SEQ ID Nos. as listed below.
- the invention is directed to a Bacillus strain of the invention, wherein i) the mutant of the strain as deposited under accession number DSM 34306 comprises 16S rDNA having at least 98% sequence identity to SEQ ID NO:1; ii) the mutant of the strain as deposited under accession number DSM 34307 comprises 16S rDNA having at least 98% sequence identity to SEQ ID NO:2; iii) the mutant of the strain as deposited under accession number DSM 34304 comprises 16S rDNA having at least 98% sequence identity to SEQ ID NO:3; or iv) the mutant of the strain as deposited under accession number DSM 34305 comprises 16S rDNA having at least 98% sequence identity to SEQ ID NO:4.
- the term "mutant”, as used herein, may refer to at least one fragment or the full length sequence of SEQ ID Nos. 1 , 2, 3 or 4.
- Such a fragment or full length sequence comprises or encodes for a 16S rRNA having at least 100, at least 200, at least 300, at least 500, at least 700, at least 900, at least 1100, at least 1300 or at least 1500 successive nucleotides of the original sequence.
- the term "mutant" relates not only to at least one fragment, but also a nucleotide sequence or a fragment thereof that are at least 98, 98.2, 98.4, 98.6, 98.8, 99.0, 99.2, 99.4, 99.5, 99.6, 99.7, 99.8 or 99.9 % identical to the reference nucleotide sequence referred to.
- Known methods comprise various methods that may be used to align two given nucleic acid or amino acid sequences and to calculate the degree of identity, see for example Arthur Lesk (2008), Introduction to bioinformatics, Oxford University Press, 2008, 3rd edition.
- the Cl ustalW software (Larkin, M.
- the mutant has at least 98% sequence identity to the sequence according to SEQ ID Nos. 1 , 2, 3 or 4. In preferred embodiments, the mutant has at least 99% sequence identity to the sequence according to SEQ ID Nos. 1, 2, 3 or 4. In even more preferred embodiments, the mutant has at least 99.5% sequence identity to the sequence according to SEQ ID Nos. 1 , 2, 3 or 4.
- mutants of the strains as deposited under accession numbers DSM 34306, DSM 34307, DSM 34304 and DSM 34305 comprise 16S rDNA having at least 98% sequence identity to SEQ ID Nos. 1, 2, 3 and 4, respectively, these mutants have a genome that contains at least one (circulated) nucleotide strand that hybridizes to the complementary nucleotide strand of the corresponding wildtype genome under high stringency conditions. Preferably, both strands of the mutant hybridize to their corresponding wildtype strands, respectively, under stringent conditions.
- strain as deposited under accession number DSM 34306 comprises 16S rDNA having at least 98% sequence identity to SEQ ID Nos. 1 and has a genome that contains at least one (circulated) nucleotide strand that hybridizes to the complementary nucleotide strand of the genome of the strain as deposited under accession number DSM 34306 under high stringency conditions.
- strain as deposited under accession number DSM 34307 comprises 16S rDNA having at least 98% sequence identity to SEQ ID Nos. 2 and has a genome that contains at least one (circulated) nucleotide strand that hybridizes to the complementary nucleotide strand of the genome of the strain as deposited under accession number DSM 34307 under high stringency conditions.
- strain as deposited under accession number DSM 34304 comprises 16S rDNA having at least 98% sequence identity to SEQ ID Nos.
- strain as deposited under accession number DSM 34305 comprises 16S rDNA having at least 98% sequence identity to SEQ ID Nos. 4 and has a genome that contains at least one (circulated) nucleotide strand that hybridizes to the complementary nucleotide strand of the genome of the strain as deposited under accession number DSM 34305 under high stringency conditions. More preferably, the hybridization of the mutants is tested under very high stringency conditions.
- nucleic acids similar sequences can also be determined by hybridization using respective stringency conditions.
- high stringency conditions means for probes of at least 100 nucleotides in length, prehybridization and hybridization at 42°C in 5X SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, following standard Southern blotting procedures for 12 to 24 hours. The carrier material is finally washed three times each for 15 minutes using 2X SSC, 0.2% SDS at 65°C.
- very high stringency conditions means for probes of at least 100 nucleotides in length, prehybridization and hybridization at 42°C in 5X SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, following standard Southern blotting procedures for 12 to 24 hours.
- the carrier material is finally washed three times each for 15 minutes using 2X SSC, 0.2% SDS at 70°C.
- the present invention is directed to a composition comprising at least one Bacillus strain of the invention and at least one additional component.
- the additional component is selected from group consisting of one or more surfactants and/or one or more builders and/or one or more preservative agents and/or one or more enzymes and/or one or more solvents, preferably one or more surfactants and/or one or more solvents.
- surfactant (synonymously used herein with “surface active agent”) means an organic chemical that, when added to a liquid, changes the properties of that liquid at an interface. According to its ionic charge, a surfactant is called non-ionic, anionic, cationic, or amphoteric.
- builder may refer to a compound or substance that may stabilize another compound or composition by neutralizing the compound or composition. Further, builders may sequester calcium and magnesium hardness ions that might otherwise bind with and render the auxiliary surfactants or co-surfactants less effective.
- a “sequestering builder”, as used herein, is different from a precipitating builder in that no significant amount of precipitate is formed when the builder is used in an amount sufficient to combine with all of the calcium ions in an aqueous solution with 7 °dH hardness (German hardness) initially at neutral pH.
- a “strong builder” is classified as high efficiency chelators that can bind the divalent cations such as Ca 2+ strongly with a logarithmic stability constant (Log KCa) of the cation/chelator complex of above 4, particular above 5, above 6 or above 7.
- the stability constants are determined at an ionic strength of 0.1 M and at a temperature of 25°C.
- a ..strong sequestering builder combines both of the above-mentioned properties.
- the solvent may be water and/or an organic solvent.
- the organic solvent may be a water-miscible solvent.
- the organic solvent may be one or more selected from the group consisting of glycerol, propanediol, polypropylene glycol, and polyethylene glycol.
- preservative agent refers to an agent that is a chemical compound that controls microorganisms or inhibits their growth or reproduction or, dependent on their concentration, even kills microorganisms.
- a preservative may be an antimicrobial agent which may be added to aqueous products and compositions to maintain the original performance, characteristics and integrity of the products and compositions by inhibiting the growth of microorganisms or even killing them dependent on the concentration of the preservative agent.
- composition/formulation may contain one or more preservatives as listed in patent WO2021/115912 A1 (“Formulations comprising a hydrophobically modified polyethyleneimine and one or more enzymes”) on pages 35 to 39.
- preservatives as listed in patent WO2021/115912 A1 (“Formulations comprising a hydrophobically modified polyethyleneimine and one or more enzymes”) on pages 35 to 39.
- preservatives are any of the following preservatives:
- 4,4’-dichloro 2-hydroxydiphenyl ether further names: 5-chloro-2-(4-chlorophenoxy) phenol, Diclosan, DCPP), Tinosan® HP 100 (commercial product of BASF SE containing 30% of active 4,4’-dichoro 2-hydroxydiphenylether); 2-Phenoxyethanol (further names: Phenoxyethanol, Methylphenylglycol, Phenoxetol, ethylene glycol phenyl ether, Ethylene glycol monophenyl ether, 2-(phenoxy) ethanol, 2-phenoxy-1-ethanol); 2-bromo-2- nitropropane-1,3-diol (further names: 2-bromo-2-nitro-1,3-propanediol, Bronopol);
- Glutaraldehyde (further names: 1-5-pentandial, pentane-1 , 5-dial, glutaral, glutar-dialdehyde); Glyoxal (further names: ethandial, oxylaldehyde, 1,2-ethandial); 2-butyl-benzo[d]isothiazol-3- one (“BBIT”); 2-methyl-2H-isothiazol-3-one (“MIT”); 2-octyl-2H-isothiazol-3-one (“OIT”); 5- Chloro-2-methyl-2H-isothiazol-3-one (“GIT” or“CMIT”); Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (“OMIT”) and 2-methyl-2H-isothiazol-3-one (“MIT”) (Mixture of CMIT/MIT); 1 ,2-benzisothiazol-3(2H)-one (“BIT”); Hexa-2,4-dienoic acid (trivial
- At least one preservative may be added to the inventive composition in a concentration of 0.001 to 10% relative to the total weight of the composition.
- the composition contains 2-phenoxyethanol in a concentration of 0.1 to 2% or 4,4’-dichloro 2- hydroxydiphenyl ether (DCPP) in a concentration of 0.005 to 0.6%.
- Preferred preservative agents for hard surface cleaning composition are selected from 2-Phenoxyethanol, Bronopol and formic acid.
- the at least one additional component may be an enzyme added in additional to the enzymes secreted by the Bacillus strain of the invention.
- the enzyme which is not derived from the strain of the invention, is classified as an oxidoreductase (EC 1), a transferase (EC 2), a hydrolase (EC 3), a lyase (EC 4), an isomerase (EC 5), or a ligase (EC 6).
- EC-numbering is according to Enzyme Nomenclature, Recommendations (1992) of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology including its supplements published 1993-1999.
- the enzyme is a hydrolase (EC 3).
- the enzyme which is not derived from the strain of the invention, is selected from the group consisting of proteases, amylases, lipases, cellulases, mannanases, hemicellulases, phospholipases, esterases, pectinases, lactases, peroxidases, xylanases, cutinases, pectate lyases, keratinases, reductases, oxidases, phenoloxidases, lipoxygenases, ligninases, pullulanases, tannases, pentosanases, malanases, beta- glucanases, arabinosidases, hyaluronidases, chondroitinases, laccases, nucleases, DNase, phosphodiesterases, phytases, carbohydrases, galactanases, xanthanases, xyloglucanases, oxid
- the enzyme is selected from the group consisting of proteases, amylases, lipases, cellulases, mannanases, xylanases, DNases, dispersins, pectinases, oxidoreductases, and cutinases, and combinations of at least two of the foregoing types.
- the enzyme which is not derived from the strain of the invention, is a protease, preferably, a serine protease, more preferably, a subtilisin protease.
- the composition is a detergent composition, more preferably a laundry detergent composition, a hard surface cleaning detergent composition, a sanitary or kitchen cleaner or an anti-malodor product.
- it is a cleaning composition and/or fabric and home care product, comprising at least one Bacillus strain of the invention, as defined above, preferably for improved oily and fatty stain removal, preferably a laundry detergent formulation and/or a manual dish wash detergent formulation, more preferably a liquid laundry detergent formulation and/or a liquid manual dish wash detergent formulation and/or sanitary cleaner.
- the cleaning composition may be used for soil removal of particulate stains and/or oily and fatty stains, and additionally for whiteness maintenance, preferably in laundry care.
- the cleaning composition of the present invention is a hard surface cleaning composition that may be used for cleaning various surfaces such as hard wood, tile, ceramic, plastic, leather, metal, or glass.
- the cleaning composition of the present invention is a liquid or solid automatic dish wash detergent composition, preferably a solid automatic dish wash detergent composition, that may be used for cleaning dish ware, e.g., dish ware such as glasses.
- the present invention is directed to a method to improve detergency of a detergent formulation by adding at least one Bacillus strain of the invention to a detergent formulation.
- the present invention is directed to a cleaning method comprising contacting at least one Bacillus strain of the invention or a composition of the invention with an object that requires cleaning, preferably a laundry or a hard surface household item.
- object that requires cleaning
- the object refers to any object possessing a surface that attracts soil.
- the object can be one that has a flexible structure, such as laundry.
- the object is a household item having a solid and hard surface.
- Such objects include smaller movable objects, such as dishes, glasses, and tiles.
- Bacillus strains of the invention are used in cleaning methods and formulations that are associated with the storage of food, in particular the storage of milk and milk or dairy products, such as, but not limited to, cream, butter, yogurt, cheese, condensed milk, kefir, milk powder, sour cream, creme fraiche, ymer, custard, chocolate, and ice cream.
- the present invention is directed to a method to reduce malodor comprising contacting at least one Bacillus strain of the invention or a composition of the invention with an object that requires cleaning, preferably a laundry or a hard surface household item.
- the present invention is directed to a method to control or reduce malodor- causing microorganisms comprising contacting at least one Bacillus strain of the invention or a composition of the invention with an object or with a medium on/in which said microorganisms is present or grows.
- malodor-causing microorganism contains all forms of microorganisms, such as bacteria, archaea, fungi and protozoa that are directly or indirectly responsible for unpleasant odor. In preferred embodiments, these microorganisms are psychrotrophs.
- Psychrophiles or “cryophiles” are extremophilic organisms that are capable of growth and reproduction in low temperatures, ranging from -20 °C to 20 °C. They have an optimal growth temperature at 15 °C. Many such organisms are bacteria or archaea, but also some eukaryotes such as lichens, snow algae, phytoplankton, fungi, and wingless midges, are classified as psychrophiles.
- medium refers to a solution containing nutrients that nourish growing microorganisms, e.g., bacteria.
- these solutions provide essential and nonessential amino acids, vitamins, energy sources, lipids, and trace elements required by the cell for minimal growth and/or survival.
- the solution may also contain components that enhance growth and/or survival above the minimal rate.
- the solution has a pH and salt concentration allowing cell survival and proliferation.
- the present invention is directed to the use of a Bacillus strain as deposited under accession number DSM 34306, DSM 34307, DSM 34304 or DSM 34305 for malodor inhibition.
- compositions of the invention comprise at least one microorganism as described herein.
- the microorganisms should be present in effective amounts.
- the terms "effective amount”, “effective concentration” or “effective dosage” are defined herein as the amount, concentration or dosage of one or more odor-controling microbial strains that can inhibit the malodor caused by the odor causing organism or substances derived therefrom on articles, articles subjected to a cleaning machine or cleaning process, and/or cleaning machines.
- the composition of the invention comprises 0.001-5% by weight Bacillus strain of the invention.
- the weight of the spores may be the weight of dry spores or wet biomass, preferably dry spores.
- compositions can be solid, semi-solid or gel-like, liquid (including spray) or an aerosol. They can be formulated in all types usual for the respective application, such as bars, powders, granulates, agglomerates, pastes, gels, solutions, emulsions, suspensions, etc. They can also be formulated as liquid composition imbibed in wipes or pads.
- compositions generally contain a carrier.
- the carrier is or comprises a solvent, mostly water, (and/or) an alkanol (generally a C2-C3- alkanol, i.e. ethanol, n-propanol and/or isopropanol; these generally also act as wetting agents to allow a better wetting or penetration of the treated substrate by the composition; this latter effect is particularly useful if no surfactant is contained in the composition), an organic solvent different therefrom (details to such further solvents are given below in context with preferred embodiments of the composition) or a mixture thereof.
- the carrier is or comprises a solid carrier.
- the soap component e.g. the solid salt of long-chained fatty acids
- the carrier is generally also the carrier.
- compositions generally comprise further components.
- examples are pH adjusting agents, sequestrants, thickeners, antifreezing agents, antifoaming agents, colorants, or perfumes. Further details to such further components are given below in context with preferred embodiments of the composition.
- the (liquid) composition comprises
- (h) ad 100% by weight, but at least 30% by weight, relative to the total weight of the composition, of water.
- at least one of components (c) to (g) is present. More preferably, at least component (c) is present.
- Surfactants can be anionic, cationic, non-ionic or amphoteric (zwitterionic).
- Anionic, cationic, non-ionic and amphoteric surfactants are widely known in the art.
- Anionic surfactants are, for example, of the sulfate, sulfonate or carboxylate type or mixed forms thereof. Examples are
- - alkyl sulfates (generally of the formula R-O-SCh' M + , where R is a long-chained alkyl group, e.g. Cs-C24-alkyl, and M + is a cation equivalent, generally Na + , K + , NH4 + , mono-, di- or triethanolammonium); e.g. sodium lauryl sulfate;
- alkyl ether sulfates (generally of the formula R-(CH2CH2-O) X -O-SO3‘ M + , where R is a long- chained alkyl group, e.g. Cs-C24-alkyl, x is 1-10 and M + is a cation equivalent, generally Na + , K + , NH4 + , mono-, di- or triethanolammonium); e.g. so-dium laureth sulfate (SLES);
- alkylbenzenesulfonates (generally of the formula R-(CeH4)-SO3' M + , where R is a long- chained alkyl group, e.g. Cs-C24-alkyl, and M + is a cation equivalent, generally Na + , K + , NH 4 + , mono-, di- or triethanolammonium); e.g. sodium dodecylbenzene sulfonate;
- - olefin sulfonates (generally of the formula R-SCh' M + , where R is a long-chained monoolefin group, e.g. Ci2-C24-alkenyl, and M + is a cation equivalent, generally Na + , K + , NH 4 + , mono-, di- or triethanolammonium); e.g. sodium Ci4/Ci6-a-olefin sulfonate;
- alkane sulfonates (generally of the formula R-SCh' M + , where R is a long-chained alkyl group, e.g. Cs-C24-alkyl, and M + is a cation equivalent, generally Na + , K + , NH 4 + , mono-, di- or triethanolammonium); e.g. alkali metal or ammonium C13-C17 paraffin sulfonate;
- - sulfated monoglycerides (generally of the formula R-COO-CH2-CH(OH)-CH2-O-SC>3' M + , where R is a long-chained alkyl group, e.g. Cs-C24-alkyl, and M + is a cation equivalent, generally Na + , K + , NH 4 + , mono-, di- or triethanolammonium); e.g. sodium cocomonoglyceride sulfate;
- alkyl sulfosuccinates e.g. disodium N-octadecylsulfosuccinamate, diammonium lauryl sulfosuccinate, tetrasodium N-(1 ,2-dicarboxyethyl)-N-octadecylsulfosuccinate; diamyl ester of sodium sulfosuccinic acid, dihexyl ester of sodium sulfosuccinic acid, or dioctyl ester of sodium sulfosuccinic acid;
- - acyl taurates e.g. N-alkyltaurins, e.g. prepared by reacting dodecylamine with sodiumisethionate or N-acyltaurines obtained by the reaction of N-methyl taurine with fatty acids;
- - acyl isethionates (generally of the formula R-COO-CH 2 CH 2 -SO 3 - M + , where R is a long- chained alkyl group, e.g. C 10 -C 30 -alkyl, and M + is a cation equivalent, generally Na + , K + , NH 4 + , mono-, di- or triethanolammonium); e.g.
- alkyl glycerylether sulfonates (generally of the formula R-O-CH2-CH(OH)-CH2-SO3- M + , where R is a long-chained alkyl group, e.g. C8-C24-alkyl, and M + is a cation equivalent, generally Na + , K + , NH4 + , mono-, di- or triethanolammonium); e.g.
- cocoglyceryl ether sulfonate - sulfonated fatty acids and sulfonate fatty acid methyl esters (generally of the formula R- CH(SO 3 M + )-COOH and R-CH(SO 3 M + )-COOCH 3 , where R is a long-chained alkyl group, e.g. C 8 -C 24 -alkyl, and M + is a cation equivalent, generally Na + , K + , NH 4 + , mono-, di- or triethanolammonium); e.g.
- acyl glutamates generally of the formula R-CO-N(COOH)-CH2CH2-COO- M + , where R is a long-chained alkyl group, e.g. C 8 -C 24 -alkyl, and M + is a cation equivalent, generally Na + , K + , NH 4 + , mono-, di- or triethanolammonium); e.g.
- acyl sarcosinates generally of the formula R-CO-N(CH3)-CH2-COO- M + , where R is a long-chained alkyl group, e.g. C8-C24-alkyl, and M + is a cation equivalent, generally Na + , K + , NH4 + , mono-, di- or triethanolammonium); e.g.
- alkyl/alkenyl moiety containing, inter alia, oleate, linolate, palmitate, myristate, stearate etc.
- the counter cation is generally Na + , K + , NH4 + , mono-, di- or triethanolammonium
- - alkyl and alkenyl ether carboxylates generally of the formula R-(OCH 2 CH 2 ) x -OCH 2 -COO- M + , where R is a long-chained alkyl or alkenyl group, e.g.
- M + is a cation equivalent, generally Na + , K + , NH 4 + , mono-, di- or triethanolammonium); e.g. sodium laureth carboxylate; - acylated peptides, - acyl lactylates (generally of the formula R-CO-[OCH(CH3)-CO]x-COO- M + , where R is a long-chained alkyl or alkenyl group, e.g.
- M + is a cation equivalent, generally Na + , K + , NH 4 + , mono-, di- or triethanolammonium); e.g. sodium cocoyl lactylate.
- Another class of suitable anionic surfactants are polyalkoxylate polycarboxylated surfactants, e.g. as described in US 5,376,298, EP-A-0129328, WO 03/018733 US 5,120,326.
- the polyalkoxylate polycarboxylated surfactant can be described by the formula R-O-(C 2 H 4 O) x - [CH(L)CH(L)] y -[CH 2 CH(CH 3 )O) z Q
- R is a hydrophobic hydrocarbon group, preferably alkyl, containing from 6 to 16, preferably from 8 to 14 carbon atoms
- x is a number from 0 to 60, preferably from 4 to 50, more preferably from 6 to 50
- L is either a C 1 -C 3 alkyl group or a group having the formula - CH(COO-)-CH 2 (COO-), with at least one L group in each molecule being -CH(COO-)- CH 2 (COO-)
- y is a number from 1 to 12, preferably from 2 to 10, more preferably from 3 to 8
- z is a number from 0 to 20, preferably from 0 to 15, more preferably from 0 to 10
- Q is selected from the
- Such polyalkoxylate polycarboxylate surfactants are commercially available under the Plurafac® brand of BASF, e.g. Plurafac® CS-10.
- Cationic surfactants are, for example, ammonium salts such as C 8 -C 16 - dialkyldimethylammonium halides, dialkoxydimethylammonium halides or imidazolinium salts with a long-chain alkyl radical.
- Non-ionic surfactants are typically the condensation products of one or more alkylene oxide, mostly ethylene oxide, with various reactive hydrogen-containing compounds having hydrophobic chains, for example with 8-24 carbon atoms, e.g.
- alkoxylated alcohols are listed in the following. They are of course only suitable as component (c) if they differ from the alkoxylated alkanols of component (b), i.e. if they are no C6-C14-alkanols alkoxylated with 3 to 5 units of ethylene oxide on average, e.g.
- another alkylene oxide e.g. only with propylene oxide, PO
- alkylene diol e.g. only with propylene-1,2- or with 1,3-diol
- Suitable alkoxylated, advantageously ethoxylated, alcohols are especially alkoxylated, advantageously ethoxylated, primary alcohols having preferably 8 to 18 carbon atoms and an average of 1 to 20, preferably 1 to 12, mol of ethylene oxide (EO) per mole of alcohol, in which the alcohol radical may be linear or branched, in particular 2-methyl-branched, or may comprise linear and methyl-branched radicals in a mixture, as are typically present in oxo alcohol radicals.
- EO ethylene oxide
- alkyl alcohols synthesized by the Guerbet process for example, 2-ethylhexanol, 2-n-propylheptanol, 2-isopropyl-heptanol, 2-n-butyloctanol, and 2- n-pentylnonanol, preferred are 2-ethylhexanol, 2-n-propylheptanol, and 2-isopropyl-heptanol. More preference is given to 2-n-propylheptanol.
- Nonionic surfactants synthesized from this latter alcohol are marketed by BASF under the brand names Lutensol® XP and Lutensol® XL.
- ethoxylated alkyl alcohols have a higher degree of branching, especially ethoxylated alkyl alcohols available under the BASF brand names Lutensol® TO Lutensol® ON and Lutensol® TDA.
- Suitable are also alcohol ethoxylates with linear radicals formed from alcohols of native origin having 12 to 18 carbon atoms, for example from coconut alcohol, palm alcohol, tallow fat alcohol or oleyl alcohol, and an average of 2 to 12 EO per mole of alcohol.
- the preferred ethoxylated alcohols include, for example, Ci2-Ci4-alcohols with 7 EO or 10 EO, C9-C11- alcohol with 7 EO or 10 EO, Ci3-Cis-alcohols with 7 EO, 8 EO or 10 EO, Ci2-Ci8-alcohols with 7 EO or 10 EO and mixtures thereof.
- the degrees of ethoxylation stated are statistical averages which, for a specific product, may be an integer or a fraction. Also suitable are alcohol ethoxylates which have a narrowed homolog distribution (narrow range ethoxylates, NRE).
- NRE narrow range ethoxylates
- fatty alcohols with more than 12 EO examples thereof are tallow fat alcohol with 14 EO, 25 EO or 30 EO.
- alkoxylated alcohols which comprise EO and PO groups together in the molecule. In this case, it is possible to use block copolymers with EO-PO block units or PO- EO block units, but also EO-PO-EO copolymers or PO-EO-PO copolymers.
- mixed-alkoxylation nonionic surfactants in which EO and PO units are not in blockwise but in random distribution. Such products are obtainable by the simultaneous action of ethylene oxide and propylene oxide on fatty alcohols.
- Suitable alkoxylated, preferably ethoxylated or ethoxylated and propoxylated, fatty acid alkyl esters preferably have 1 to 4 carbon atoms in the alkyl chain and are especially fatty acid methyl esters.
- Non-ethoxylated non-ionic surfactants are for example sugar surfactants, glycerol monoethers, polyhydroxyamides (glucamide) or amine oxides.
- Sugar surfactants are for example alkyl and/or alkenyl polyglycosides, sugar or alkyl sugar fatty acid esters, and fatty sugar amides.
- Alkyl and/or alkenyl polyglycosides are nonionic surfactants with a carbohydrate as hydrophilic moiety and fatty alcohols or fatty acids as hydrophobic component. Examples are compounds of the formula
- R-O-Gp where R is a long-chained alkyl or alkenyl group, mostly with 4-22 carbon atoms, G is an aldose or ketose moiety, mostly a glucose moiety, and p is from 1 to 10.
- component G is preferably derived from aldoses or ketoses having 5 or 6 carbon atoms.
- component G is selected from the group of hexoses, preferably from the group consisting of allose, altrose, glucose, mannose, gulose, idose, galactose, talose, psicose, fructose, sorbose and tagatose, and is more preferably glucose.
- component G is selected from the group of pentoses, preferably from the group consisting of ribulose, xylulose, ribose, arabinose, xylose and lyxose, and more preferably from xylose and arabinose.
- the index number p in the above formula gives the degree of polymerization (DP), and is a number between 1 and 10. In one embodiment p is of from 1 .1 to 3.0.
- R can be linear or branched.
- the radical R is derived from linear primary alcohols, e.g. fatty alcohols, or from branched primary alcohols, in particular so-called oxo alcohols.
- R derived from linear primary alcohols are n-octyl, n-nonyl, n-decyl, n- undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecly, n-heptadecyl or n-octadecyl.
- R derived from branched primary alcohols are isoamyl, isohexyl, isoheptyl, 2- ethylhexyl and 2-propylheptyl.
- alkyl and/or alkenyl polyglycosides are for example products sold under the PLANATAREN® and PLANTACARE® brands from Henkel, e.g. PLANTAREN 1200, PLANTAREN 1300, PLANTAREN 2000, PLANTACARE 2000, PLANTACARE 818, PLANTACARE 1200; products sold under the TRITON® CG brand from Seppic, e.g. TRITON CG 110 (or ORAMIX CG 110) and TRITON CG 312 (or ORAMIX NS 10); the product sold as LUTENSOL® GD 70 from BASF SE; the products sold under the Glucopon® brand from BASF SE, e.g.
- Sugar or alkyl sugar fatty acid esters are sugar or alkyl sugar C4-C22 fatty acid esters among which there may be mentioned in particular:
- (Ci-C4)alkyl glucoside esters such as methyl glucoside monostearate, e.g. the product sold under the name GRILLOCOSE® IS by Grillowerke; methyl glucoside sesquistearate, e.g. the product sold under the name GLUCATE SS by Amerchol; 6-ethylglucoside decanoate, e.g. the product sold under the name BIOSURF 10 by Novo; the mixture of mono- and dicocoate (82/7) of 6-ethylglucoside, e.g.
- BIOSURF® COCO the product sold under the name BIOSURF® COCO by Novo
- the mixture of mono- and dilaurate (84/8) of 6-ethylglucoside e.g. the product sold under the name BIOSURF® 12 by Novo
- the butyl glucoside C12-C18 fatty acid monoesters such as butyl glucoside monococoate, e.g. the product sold under the names REWOPOL® V3101 or REWOSAN® V3101 and polyoxyethylenated butyl glucoside monococoate with 3 moles of ethylene oxide, e.g.
- glucose esters such as 6-O-hexadecanoyl-[alpha]-D-glucose, 6-O-octanoyl-D-glucose, 6-O- oleyl-D-glucose, 6-O-linoleyl-D-glucose, which can be prepared, for example, from the corresponding acid chloride and D-glucose; sucrose monoesters such as sucrose monolaurate, e.g. the product sold under the name GRILLOTEN® LES 65, and sucrose monococoate sold under the name GRILLOTEN® LES 65K sold by the company Grillo- Maschinene.
- the fatty sugar amides are compounds comprising at least one amide function and including at least one sugar or sugar derivative portion and at least one fatty chain; such compounds may, for example, result from the action of a fatty acid or a fatty acid derivative on the amine function of an amino sugar, or from the action of a fatty amine on a sugar comprising a carboxylic acid function (free or in lactone form) or carboxylic acid-derived function or alternatively a carbonyl function, and optionally in the presence of suitable co-reagents.
- Examples are N-substituted aldonamides polyhydroxylated fatty acid amides or mixtures thereof.
- N-substituted aldonamides are for example N-substituted lactobionamides, N-substituted maltobionamides, N-substituted cellobionamides, N-substituted mellibionamides and N- substituted gentiobionamides such as:
- N-alkyllactobionamides, N-alkylmaltobionamides, N-alkylcellobionamides, N- alkylmellibionamides or N-alkylgentiobionamides which are mono- or disubstituted with a saturated or unsaturated, linear or branched, aliphatic hydrocarbon group which may contain heteroatoms preferably having up to 36 carbon atoms, more preferably up to 24 carbon atoms and still more particularly from 8 to 18 (for example methyl, ethyl, amyl, hexyl, heptyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl; allyl, undecenyl, oleyl, linoleyl, propenyl, hepten
- N-(alkyloxy)alkyllactobionamides which are mono- or disubstituted with a group -(CH 2 )n-OR’, where R’ is an aliphatic, aromatic or cycloaliphatic hydrocarbon group; N-(polyalkyloxy)alkyllactobionamides, N-(polyalkyloxy)alkylmaltobionamides, N-(polyalkyloxy)alkylcellobionamides, N-(polyalkyloxy)alkylmellibionamides or
- N-(polyalkyloxy)alkylgentiobionamides which are mono- or disubstituted with a group -R’-(OR’) n R’R” where R’ is an alkylene group such as ethylene, propylene or mixtures thereof, n is an integer greater than 1, R” is a lactobionamide, maltobionamide, cellobionamide, mellibionamide or gentiobionamide group.
- polyhydroxylated fatty amides are compounds of the formula
- T denotes a C5-C31 hydrocarbon group, preferably a C7-C15 linear alkyl or alkenyl chain
- V denotes hydrogen, a C1-C4 hydrocarbon radical, 2-hydroxyethyl, 2-hydroxypropyl or mixtures thereof, preferably a C 1 -C 4 alkyl such as methyl, ethyl, propyl, isopropyl, N-butyl and more particularly methyl
- W denotes a polyhydroxy hydrocarbon-containing group having a linear hydrocarbon chain with at least 3 hydroxyl groups directly attached to the chain, or an alkoxylated derivative of the said group (preferably ethoxylated or propoxylated).
- W is preferably a reducing sugar derivative obtained by reductive amination reaction and more preferably a glycityl group.
- Glucose, maltose, lactose, galactose, mannose and xylose may be mentioned among the reducing sugars.
- W is chosen from the groups of the following formulae: -(CH 2 )-(CHOH) n -CH 2 OH; -CH-(CH 2 OH)-(CHOH) n-1 -CH 2 OH; and -CH 2 - (CHOH) 2 (CHOR')-(CHOH)-CH 2 OH, in which n is an integer ranging from 3 to 5, and R' is hydrogen, a cyclic or aliphatic monosaccharide or one of its alkoxylated derivatives.
- Non-ionic surfactants of the amine oxide type are generally of the formula R a R b R c N + -O-, where R a is a long-chained alkyl group, e.g. C -C -alkyl, preferabl b 10 18 y C12-C16-alkyl, and R and R c are short-chained alkyl or hydroxyalkyl groups, such as methyl, ethyl or 2- hydroxyethyl.
- a specific example is lauryldimethylamine oxide.
- the long-chained alkyl group can be derived from native sources (oils or fats), resulting in mixtures of such amine oxides, for example N-cocoalkyl-N,N-dimethylamine oxide and N-tallowalkyl-N,N- dihydroxyethylamine oxide.
- Amphoteric surfactants are, for example, derivatives of secondary or tertiary amines, for example C6-C18-alkyl betaines (e.g. cocoamidopropyl betaine; disodium cocoamphodiacetate (DSCADA)) or C6-C18-alkyl sulfobetaines, or amine oxides such as alkyldimethylamine oxides.
- C2-C3-Alkanols are ethanol, n-propanol and isopropanol. Mixtures thereof are also suitable.
- the organic solvents different from component (d) [component (e)] generally serve for providing a stable composition, especially if the composition is a concentrate containing high amounts of organic matter. 220499 30 Suitable solvents are thus polar protic or polar aprotic.
- suitable solvents (e) are alkanols different from C2-C3-alkanols, such as n-butanol or tert-butanol; C2-C8-alkanediols; C 1 -C 8 -alkylmonoethers of C 2 -C 8 -alkanediols; diglycols, C 1 -C 8 -alkylmonoethers of diglycols, polyetherpolyols; C 1 -C 8 -alkylmonoethers of polyetherpolyols; amino alcohols, such as ethanolamine, diethanolamine and triethanolamine; monophenyl ethers of C 2 -C 3 -alkanediols, such as 2-phenoxyethanol or phenoxypropanol.
- alkanols different from C2-C3-alkanols such as n-butanol or tert-butanol
- C 2 -C 4 -alkanediols in particular ethylene glycol and propylene glycol, C 1 -C 4 -alkylmonoethers of a C 2 -C 3 -alkanediol, such as the C 1 -C 4 -alkylmonoethers of ethylene glycol or propylene glycol, specific examples being ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol mono-n-propyl ether, ethylene glycol mono- n-butyl ether (also termed butylglyol), propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol mono-n-propyl ether, and propylene glycol mono-n-butyl ether; and to C 1 -C 4 -alkylmonoethers of diglycols, for example butyldiglycol, and n-hex
- Sequestrants [components (f)], also termed builders, structural substances, framework substances, complexing agents, chelators, chelating agents or softeners, bind alkaline earth metals and other water-soluble metal salts without precipitating. They help to break up soil, disperse soil components, help to detach soil and in some cases themselves have a washing effect. Many of the sequestrants listed below are multi-functional, meaning that the substances have additional functions, such as a dispersing activity. Suitable sequestrants may be either organic or inorganic in nature.
- Examples are aluminosilicates, carbonates, phosphates and polyphosphates, polycarboxylic acids, polycarboxylates, hydroxycarboxylic acids, phosphonic acids, e.g. hydroxyalkylphosphonic acids, phosphonates, aminopolycarboxylic acids and salts thereof, and polymeric compounds containing carboxylic acid groups and salts thereof.
- Suitable inorganic sequestrants are, for example, crystalline or amorphous aluminosilicates with ion-exchanging properties, such as zeolites.
- Crystalline silicates suitable as sequestrants are, for example, disilicates or sheet silicates, e.g.
- Suitable inorganic sequestrant substances based on carbonate are carbonates and hydrogencarbonates. These can be used in the form of their alkali metal, alkaline earth metal or ammonium salts.
- Customary phosphates used as inorganic 220499 31 sequestrants are alkali metal orthophosphates and/or polyphosphates, for example pentasodium triphosphate.
- Suitable organic sequestrants are, for example, C 4 -C 30 -di-, -tri- and -tetracarboxylic acids, for example succinic acid, propanetricarboxylic acid, butanetetracarboxylic acid, cyclopentanetetracarboxylic acid, and alkyl- and alkenylsuccinic acids with C 2 -C 20 -alkyl or - alkenyl radicals.
- Suitable organic sequestrants are also hydroxycarboxylic acids and polyhydroxycarboxylic acids (sugar acids).
- C 4 -C 20 -hydroxycarboxylic acids for example malic acid, tartaric acid, glutonic acid, mucic acid, lactic acid, glutaric acid, citric acid, tartronic acid, glucoheptonic acid, lactobionic acid, and sucrosemono-, -di- and -tricarboxylic acid.
- citric acid and salts thereof preference is given to citric acid and salts thereof.
- Another class are carboxylated fructans. Fructans are polymers of fructose molecules. They are built up of fructose residues, normally with a sucrose unit (i.e. a glucose-fructose disaccharide) at what would otherwise be the reducing terminus.
- the linkage of the fructose residues normally occurs at one of the two primary hydroxyls (OH-1 or OH-6).
- the fructosyl residues are linked by ⁇ -2,1-linkages.
- the fructosyl residues are linked by ⁇ -2,6-linkages.
- the graminin type contains both ⁇ -2,1-linkages and ⁇ -2,6-linkages.
- the carboxylated fructans are derived from inulin. Particular examples are carboxymethylinulin and carboxyethylinulin. Suitable carboxylated fructans are described in EP 3561032 A1 and WO 2010/106077.
- Suitable organic sequestrants are moreover polyasparatic acids.
- Polyaspartic acid include salts of 220499 32 polyaspartic acids. Salt forming cations may be monovalent or multivalent, examples being sodium, potassium, magnesium, calcium, ammonium, and the ammonium salt of mono-, di- and triethanolamine.
- Such polymers may be co-polymers, in particular of (a) L- or D-aspartic acid (preferably L-aspartic acid), (b) a carboxylic acid and (c) a diamone or an amino alcohol.
- Such copolymers generally comprise 70-95 mol% of (a), 5-30 mol% of (b) and 2-20 mol% of (c).
- the molar ratio of the carboxyl-containing compound (b) to the diamine or amino alcohol (c) is preferably between 5:1 and 1:1.5 or between 3:1 and 1:1.2, and more preferably between 3:1 and 1:1 or 2:1 and 1:1.
- Suitable organic sequestrants are additionally aminopolycarboxylic acids, such as nitrilotriacetic acid (NTA), nitrilomonoacetic dipropionic acid, nitrilotripropionic acid, ⁇ -alaninediacetic acid ( ⁇ -ADA), ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), 1,3-propylenediaminetetraacetic acid, 1,2-propylenediaminetetraacetic acid, N-(alkyl)ethylenediaminetriacetic acid, N-(hydroxyalkyl)ethylenediaminetriacetic acid, ethylenediaminetriacetic acid, cyclohexylene- 1,2-diaminete
- Suitable organic sequestrants are additionally polymeric compounds containing carboxylic acid groups, such as acrylic acid homopolymers.
- carboxylic acid groups such as acrylic acid homopolymers.
- the term "acrylic acid homopolymer” also comprises polymers in which some or all of the carboxylic acid groups are present in neutralized form.
- Suitable polymeric compounds containing carboxylic acid groups are also oligomaleic acids.
- Suitable polymeric compounds containing carboxylic acid groups are also terpolymers of unsaturated C 4 -C 8 -dicarboxylic acids.
- Suitable unsaturated C 4 -C 8 -dicarboxylic acids in this context are, for example, maleic acid (or maleic anhydride), fumaric acid, itaconic acid, aconitic acid, mesaconic acid, methylenemalonic acid and citraconic acid.
- Suitable polymeric compounds containing carboxylic acid groups are also homopolymers of the monoethylenically unsaturated C3-C8-monocarboxylic acids, for example acrylic acid, methacrylic acid, crotonic acid, 2-ethylacrylic acid, 2-phenylacrylic acid, cinnamic acid, vinylacetic acid and sorbic acid, copolymers of dicarboxylic acids, for example of maleic acid and acrylic acid; terpolymers of maleic acid, acrylic acid and a vinyl ester of a C 1 -C 3 -carboxylic acid; and copolymers of maleic acid with C 2 -C 8 -olefins.
- monoethylenically unsaturated C3-C8-monocarboxylic acids for example acrylic acid, methacrylic acid, crotonic acid, 2-ethylacrylic acid, 2-phenylacrylic acid, cinnamic acid, vinylacetic acid and sorbic acid,
- pH adjusting agents for example pH adjusting agents (pH modifiers), thickeners, antifreezing agents, antifoaming agents, colorants and perfumes [i.e. different from components (a) and (b)].
- pH adjusting agents are acids or bases.
- the pH can also be adjusted by buffering systems. 220499 33
- the acids can be inorganic or organic. Suitable inorganic acids are for example sulfuric acid, hydrochloric acid and phosphoric acid, where sulfuric acid is generally preferred.
- Suitable organic acids are for example aliphatic, saturated non-substituted C 1 -C 6 -mono-, di- and tri- carboxylic acids such as formic acid, acetic acid, propanoic acid, oxalic acid, succinic acid, glutaric acid and adipic acid; aliphatic, saturated C 1 -C 6 -mono-, di- and tri-carboxylic acids carrying one or more OH groups, such as glycolic acid, lactic acid, tartric acid and citric acid; aliphatic, unsaturated C 1 -C 6 -mono-, di- and tri-carboxylic acids such as sorbic acid; aromatic carboxylic acids, such as benzoic acid, salicylic acid and mandelic acid; and sulfonic acids, such as methanesulfonic acid or toluenesulfonic acid.
- the organic acids mainly serve for adapting the pH of the composition, but some of them, e.g. the di-and tricarboxylic acids, can also act as sequestrants.
- Suitable bases are in particular inorganic bases, such as the carbonates mentioned in context with the sequestrant, e.g. sodium or potassium carbonate; further ammonium carbonate, alkali metal and earth alkaline metal bicarbonates, such as sodium hydrogencarbonate or potassium hydrogencarbonate, alkali metal and earth alkaline metal hydroxides, such as NaOH or KOH, or ammonium hydroxide.
- Organic bases can also be used; examples are alkanolamines, such as monoethanolamine, triethanolamine or aminomethylpropanol, or guanidine derivatives, such as 1,1,3,3-tetramethylguanidine or triazabicyclodecene.
- Suitable buffering agents are the typical systems, such as hydrogenphosphate/dihydrogenphosphate buffer, carbonate/hydrogencarbonate buffer, acetic acid/acetate buffer or Tris buffer.
- most of the above acids which are weak and the anion of which is not a strong salt also have buffering capacity.
- the thickeners serve to impart the desired viscosity to the composition of the invention.
- any known thickener is suitable in principle, provided that it does not exert any adverse effect on the efficacy of the composition.
- Suitable thickeners may either be of natural origin or of synthetic nature. Thickeners of natural origin are mostly derived from polysaccharides.
- xanthan examples are xanthan, gellan gum, carob flour, guar flour or gum, carrageenan, agar, tragacanth, gum arabic, alginates, modified starches such as hydroxyethyl starch, starch phosphate esters or starch acetates, dextrins, pectins and cellulose derivatives, such as carboxymethylcellulose, hydroxyethylcellulose, hydrophobically modified hydroxyethyl cellulose, 220499 34 hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose and the like.
- Thickeners of natural origin are also inorganic thickeners, such as polysilicic acids and clay minerals, for example sheet silicates, and also the silicates mentioned for the builders.
- synthetic thickeners are polyacrylic and polymethacrylic compounds, such as (partly) crosslinked homopolymers of acrylic acid, for example homopolymers of acrylic acid which have been crosslinked with an allyl ether of sucrose or pentaerythritol, or with propylene (carbomers), for example the Carbopol® brands from BF Goodrich (e.g. Carbopol® 676, 940, 941, 934 and the like) or the Polygel® brands from 3V Sigma (e.g.
- Polygel® DA copolymers of ethylenically unsaturated mono- or dicarboxylic acids, for example terpolymers of acrylic acid, methacrylic acid or maleic acid with methyl acrylate or ethyl acrylate and a (meth)acrylate which derives from long-chain ethoxylated alcohols, for example the Acusol® brands from Rohm & Haas (e.g.
- Acusol® 820 or 1206A copolymers of two or more monomers which are selected from acrylic acid, methacrylic acid and the C 1 - C 4 -alkyl esters thereof, for example copolymers of methacrylic acid, butyl acrylate and methyl methacrylate or of butyl acrylate and methyl methacrylate, for example the Aculyn® and Acusol® brands from Rohm & Haas (e.g.
- Aculyn® 22, 28 or 33 and Acusol® 810, 823 and 830), or crosslinked high molecular weight acrylic acid copolymers for example copolymers of C 10 -C 30 -alkyl acrylates with one or more comonomers selected from acrylic acid, methacrylic acid and the C1-C4-alkyl esters thereof, said copolymers having been crosslinked with an allyl ether of sucrose or pentaerythritol (e.g. Carbopol® ETD 2623, Carbopol® 1382 or Carbopol® AQUA 30 from Rohm & Haas).
- Another preferred substance group is the Rheovis® brands from BASF, e.g. Rheovis® AT 120.
- Suitable antifreezing agents are ethylene glycol, propylene glycol, urea and glycerine.
- suitable antifoaming agents are silicones, long-chain alcohols and salts of fatty acids.
- Suitable colorants e.g. in red, blue, or green
- Suitable colorants are pigments of low water solubility and water- soluble dyes.
- examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanoferrate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).
- Fragrances can be of natural or synthetic origin; their nature is in general not critical.
- the Bacillus strains of the invention may be produced via fermentation.
- the term “fermentation” refers generally to any activity or process involving the decomposition 220499 35 (digestion) of organic materials by the Bacillus strain of the invention resulting in its growth.
- fermentation as used herein is to be understood to include any type of fermentation including but not limited to substantially zero growth fermentation, i.e. a fermentation process wherein the cell density of the microorganisms applied in the fermentation process will be substantially zero and wherein the microorganisms will not undergo a significant population growth, including under-fermentation, i.e. a fermentation process wherein the fermentation is performed during an insufficient period of time, and including over-fermentation, e.g. a fermentation process wherein fermentation is performed for a too long period of time.
- the term “fermentation” encompasses both anaerobic and aerobic processes, as well as processes involving a combination or succession of one or more anaerobic and/or aerobic stages.
- the fermentation may be a continuous or a batch process.
- nutrient starvation There are two determining factors that trigger sporulation: nutrient starvation and cell density.
- the vegetative bacterial cells may be exposed to nutrient starvation in combination with a high cell density, such as an OD 600 greater than 0.3, greater than 0.4, greater than 0.5 or greater than 0.6.
- the cell density may be greater than 10 6 cells/mL, greater than 10 7 cells/mL, 10 8 cells/mL, 5*10 8 cells/mL or 10 9 cells/mL.
- the singular forms of "a” and “an” also include the respective plurals unless the context clearly dictates otherwise.
- the terms "about” and “approximately” denote an interval of accuracy that a person skilled in the art will understand to still ensure the technical effect of the feature in question.
- the term typically indicates a deviation from the indicated numerical value of ⁇ 20 %, preferably ⁇ 15 %, more preferably ⁇ 10 %, and even more preferably ⁇ 5 %.
- first”, “second”, “third” or “(a)”, “(b)”, “(c)”, “(d)” etc. and the like in the description and in the claims, are used for distinguishing between similar elements and not necessarily for describing a sequential or chronological order. It is to be understood that the terms so used are interchangeable under appropriate circumstances and that the embodiments of the invention described herein are capable of operation in other sequences than described or illustrated herein.
- first, “second”, “third” or “(a)”, “(b)”, “(c)”, “(d)”, “i”, “ii” etc. relate to steps of a method or use or assay there is no time or time interval coherence between the steps, i.e.
- a group is defined to comprise at least a certain number of members, this is meant to also encompass a group which consists of these members only.
- the present invention is further illustrated by the following examples, sequences and figures from which further features, embodiments, aspects and advantages of the present invention may be taken. Further, the materials, methods, and examples are illustrative only and are not intended to be limiting, unless otherwise specified. Examples Each strain of a collection comprising around 50 strains from a variety of different bacterial species has been tested for its ability to form spores, to provide extracellular enzyme activity and to reduce malodor according to the below protocols.
- Example 1 Spore count Before use, all strains were streaked on TSAY-agar plates (30 g/L Tryptic Soy Broth, 3 g/L yeast extract, 20 g/L agar) and incubated at 30°C for 2 days.
- sporulation experiments were performed in BA055 medium containing 10 g/L Glucose*H2O, 5 g/L yeast extract, 10 g/L Sofarin Soymeal, 10 g/L corn starch, 3.7 g/L K2HPO4 and 2.5 g/L KH2PO4 adjusted to pH 7 and sterilized at 121°C for 30 min.
- spore count measurements were performed by inoculating 1 mL BA055 medium in flower plates (m2p-labs) with a single colony. Plates were incubated at 30°C, 1000 rpm for 72 h.
- dilution series were performed by mixing 100 ⁇ L sample, with 900 ⁇ L dilution solution containing 0.9 % NaCl and 0.1 g/L Tween80 and mixed by vortexing for 30 s. Dilutions were repeated until adequate dilution.10 ⁇ L of diluted samples were spotted on agar plates, incubated for 24 h at 30°C and cells counted.
- Figure 1 shows the spore count of four bacterial strains, namely Bacillus methylotrophicus (comprising SEQ ID NO:1), Bacillus subtilis (comprising SEQ ID NO:2), Bacillus amyloliquefaciens (comprising SEQ ID NO:3) and Bacillus amyloliquefaciens (comprising SEQ ID NO:4) which had the highest total score of all bacterial strains tested.
- Bacillus methylotrophicus comprising SEQ ID NO:1
- Bacillus subtilis comprising SEQ ID NO:2
- Bacillus amyloliquefaciens comprising SEQ ID NO:3
- Bacillus amyloliquefaciens comprising SEQ ID NO:4 which had the highest total score of all bacterial strains tested.
- Example 2 Agar plate enzyme assays
- strains were streaked on NB-agar based plates (8 g/L NB (Difco), 20 g/L agar) containing further additives to allow semiquantitative visual evaluation of enzymatic activities.
- plates additionally contained 2.5 g/L red starch.
- agar plates contained 5 g/L soluble corn starch and were stained with Lugolsch solution after 48 h incubation.
- NB-agar plates additionally contained 10 g/L skim milk powder.
- lipase activity NB-agar was mixed with 10 ml/L tributyrin before pouring the agar plates.
- mannanase activity 1 g/L Locust Bean Gum was added to the NB-agar. After 48 h of incubation on plates, the respective enzyme activities were assessed visually. High enzymatic activities resulted in large, clear halo rings around bacterial colonies due to degradation of the respective substrates.
- Enzyme activities were scored semi-quantitatively from 0 (no activity) to 3 (high activity). The values of the two different assay concerning amylase activity were added and the sum was divided by two to receive an average amylase activity.
- Figure 2 shows the score for the in Example 1 described strains for each enzymatic assay tested. A total enzyme score was generated by adding the scores for the average amylase, protease, lipase and mannanase activity. This score is shown in the column “enzyme score” in Figure 3. 220499 38
- Example 3 – Odor control Strains were cultivated in 1 mL BA055 medium in flower plates (m2p-lab) at 30°C, 1000 rpm.
- Bacillus methylotrophicus comprising SEQ ID NO:1
- Bacillus subtilis comprising SEQ ID NO:2
- Bacillus amyloliquefaciens comprising SEQ ID NO:3
- Bacillus amyloliquefaciens comprising SEQ ID NO:4
- Example 4 Long-term cleaning effects (CFT tiles) 20 mL of BA055 medium in 100 mL baffled shaking flasks were inoculated with the target strains and incubated at 30°C 220 rpm for 72 h.
- the supernatant was filtered using a 0,22 ⁇ m PES filter and transferred to a glass vial and measured via HPLC (Aminex HPX-87-H (BIO-RAD), 300 x 7.8 mm, 9 ⁇ m particle size, with 0.5 M H2SO4 (Roth) as eluent and 0.5 ml/min flow rate at 30° C).
- HPLC Aminex HPX-87-H (BIO-RAD)
- Roth 0.5 M H2SO4
- a commonly found malodor compound is butyric acid, which shows a strong malodor perception at relatively low concentrations in its protonated form. Already low concentrations >0.8 g/L cause a strong odor perception.
- the sensory malodor determinations for the inventive strains as well as the control and reference strains correlate well with the proposed butyric acid concentrations and olfactory perceptions as described by Greenman et al. (see Figure 6).
- B. subtilis ATCC 6633 which was previously described as a suitable strain for probiotic cleaning applications (Vehapi, M., ⁇ zçimen, D.
- Example 7 – ADW formulations In the following there are exemplified ADW (automatic dishwasher) formulations that contain the inventive strains of the present application: Automatic Dishwasher Detergents A (wt %) B (wt %) C (wt %) Sodium Carbonate 5-10 30-40 Sodium Bicarbonate 15-25 Sodium Silicate 10-12 1-3 0.5-2 MGDA 1-7 1-7 GLDA 1-7 Nonionic surfactant 1 1-2 0.5-2 Polymer dispersant 2 3-5 Polymer with Zinc Ion 3 0.5-2 1-3 1-5 Enzymes 0-1 0-1 Bleach, bleach catalyst, 0.5-2 bleach activitor Sodium Hypochloride 0.5-1.5 Sodium Sulfate 2-5 2-5 20-60 220499 41 Sodium Benzoate 0.5-1.5 0.5
- Such formulations provide a good initial cleaning effect.
- the spores are fully stable in the formulation and upon use, spore germination is not inhibited.
- Such formulations can be used to treat general hard surfaces in the home or in offices or in commercial-, industrial-, or agricultural settings. But especially for surfaces in bathrooms, kitchens, dairies, and other places where food is stored or treated. 220499 43 220499 44
- the formulations I-a to VIII-a correspond to the same formulations as I to VIII, but with Bacillus subtilis (DSM 34307) instead of Bacillus methylotrophicus (DSM 34306).
- the formulations I-b to VIII-b correspond to the same formulations as I to VIII, but with Bacillus amyloliquefaciens (DSM 34304) instead of Bacillus methylotrophicus (DSM 34306).
- the formulations I-c to VIII-c correspond to the same formulations as I to VIII, but with Bacillus amyloliquefaciens (DSM 34305) instead of Bacillus methylotrophicus (DSM 34306).
- the following are dilutable, concentrated cleaning formulations (i.e., formulations that are diluted 10-100x with water before use) which contains XYZ spores of the invention. The spores are fully stable in the formulation.
- Such formulations can be used to treat general hard surfaces in the home or in offices or in commercial-, industrial-, or agricultural settings. But especially for surfaces in bathrooms, kitchens, dairies, and other places where food is stored or treated 220499 45
- the formulations IX-a to XVI-a correspond to the same formulations as IX to XVI, but with Bacillus subtilis (DSM 34307) instead of Bacillus methylotrophicus (DSM 34306).
- the formulations IX-b to XVI-b correspond to the same formulations as IX to XVI, but with Bacillus amyloliquefaciens (DSM 34304) instead of Bacillus methylotrophicus (DSM 34306).
- the formulations IX-c to XVI-c correspond to the same formulations as IX to XVI, but with Bacillus amyloliquefaciens (DSM 34305) instead of Bacillus methylotrophicus (DSM 34306).
- the bacterial strains of the invention are used in a laundry detergent.
- Liquid laundry detergents according to the present invention are composed of: 0.05 – 20% of at least one (anionic, non-ionic or amphoteric) polymer 1 – 50% of surfactants 0.1 – 40% of builders, cobuilders and/or chelating agents 0.1 – 50% other adjuncts 0.001 – 5 % of the bacterial strain(s) of the invention water to add up 100%.
- Preferred liquid laundry detergents according to the present invention are composed of (wt %): 0.2 – 6% of at least one (anionic, non-ionic or amphoteric) polymer 5 – 40% of anionic surfactants selected from C10-C15-LAS and C10-C18 alkyl ethersulfates containing 1-5 ethoxy-units 1.5 – 10% of non-ionic surfactants selected from C10-C18-alkyl ethoxylates containing 3 – 10 ethoxy-units 2 – 20% of soluble organic builders/co-builders selected from C10-C18 fatty acids, di- and tricarboxylic acids, hydroxy-di- and hydroxytricaboxylic acids and polycarboxylic acids 0.05 – 5% of an enzyme system containing at least one enzyme suitable for detergent use and preferably also an enzyme stabilizing system 0.5 – 20% of mono- or diols selected from ethanol, isopropanol, ethyleng
- Solid laundry detergents like e.g. powders, granules or tablets
- Solid laundry detergents are composed of: 0.05 – 20% of at least one (anionic, non-ionic or amphoteric) polymer 1 – 50% of surfactants 0.1 – 80% of builders, co-builders and/or chelating agents 0-50% fillers 0 – 40% bleach actives 0.1 – 30% other adjuncts and/or water 0.001 – 5 % of the bacterial strain(s) of the invention wherein the sum of the ingredients adds up 100%.
- anionic, non-ionic or amphoteric polymer 1 – 50% of surfactants 0.1 – 80% of builders, co-builders and/or chelating agents 0-50% fillers 0 – 40% bleach actives 0.1 – 30% other adjuncts and/or water 0.001 – 5 % of the bacterial strain(s) of the invention wherein the sum of the ingredients adds up 100%.
- Preferred solid laundry detergents according to the present invention are composed of: 0.2 – 6% of at least one (anionic, non-ionic or amphoteric) polymer 5 – 30% of anionic surfactants selected from C10-C15- LAS, C10-C18 alkylsulfates and C10-C18 alkyl ethersulfates containing 1-5 ethoxy-units 1.5 – 7.5% of non-ionic surfactants selected from C10-C18-alkyl ethoxylates containing 3 – 10 ethoxy-units 5 – 50% of inorganic builders selected from sodium carbonate, sodiumbicarbonate, zeolites, soluble silicates, sodium sulfate 220499 47 0.5 - 15% of cobuilders selected from C10-C18 fatty acids, di- and tricarboxylic acids, hydroxydi- and hydroxytricarboxylic acids and polycarboxylic acids 0.1 – 5% of an enzyme system containing at least one enzyme suitable
- the bacterial according to the present invention is used in a manual dish wash detergent.
- Liquid manual dish wash detergents according to the present invention are composed of: 0.05 – 10% of at least one (anionic, non-ionic or amphoteric) polymer 1 – 50% of surfactants 0.1 – 50% of other adjuncts 0.001 – 5 % of the bacterial strain(s) of the invention water to add up 100%.
- Preferred liquid manual dish wash detergents are composed of: 0.2 – 5% of at least one (anionic, non-ionic or amphoteric) polymer 5 – 40% of anionic surfactants selected from C10-C15- LAS, C10-C18 alkyl ethersulfates containing 1-5 ethoxy-units, and C10-C18 alkylsulfate 2 – 10% of Cocamidopropylbetaine 0 – 10% of Lauramine oxide 0 – 2% of a non-ionic surfactant, preferably a C10-Guerbet alcohol alkoxylate 0 – 5% of an enzyme, preferably Amylase, and preferably also an enzyme stabilizing system 0.5 – 20% of mono- or diols selected from ethanol, isopropanol, ethylenglycol, or propylenglyclol 0.1 – 20% other adjuncts 0.001 – 5 % of the bacterial strain(s) of the invention water to add up
- a method to control or reduce m at least one Bacillus strain accor according to one of claims 9 to 1 microorganisms is present or grows.
- new Bacillus strains are provided. More specifically, Bacillus strains having extracellular hydrolase activity and demonstrating reduced malodor after incubation for at least 5 days for at least 25 °C in a lactose-free whole milk sample compared to a non- inoculated lactose-free whole milk sample, a composition comprising these strains and methods using the new Bacillus strains are provided.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
La présente invention concerne de nouvelles souches de Bacillus. Plus particulièrement, la présente invention concerne des souches de Bacillus présentant une activité hydrolase extracellulaire et démontrant une réduction de la mauvaise odeur après incubation pendant au moins 5 jours à au moins 25 °C dans un échantillon de lait entier sans lactose par comparaison avec un échantillon de lait entier sans lactose non inoculé, une composition comprenant ces souches et des procédés utilisant les nouvelles souches de Bacillus.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22202842 | 2022-10-20 | ||
EP22202842.5 | 2022-10-20 | ||
EP23167096.9 | 2023-04-06 | ||
EP23167096 | 2023-04-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024083600A1 true WO2024083600A1 (fr) | 2024-04-25 |
Family
ID=88466591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2023/078168 WO2024083600A1 (fr) | 2022-10-20 | 2023-10-11 | Bactéries de lutte contre les odeurs |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024083600A1 (fr) |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129328A2 (fr) | 1983-06-20 | 1984-12-27 | Olin Corporation | Détergents anioniques |
US5120326A (en) | 1989-06-30 | 1992-06-09 | Olin Corporation | Anionic polycarboxylated surfactants as dye-leveling agents |
US5376298A (en) | 1993-07-29 | 1994-12-27 | The Procter & Gamble Company | Hard surface detergent compositions |
WO2000003752A1 (fr) * | 1998-07-13 | 2000-01-27 | Life Science Tgo, S.R.L. | Bacteries utiles comme agent de neutralisation d'odeurs pour moquettes |
WO2003018733A1 (fr) | 2001-08-27 | 2003-03-06 | Ecolab Inc. | Melange d'agents de surface pour une utilisation dans des compositions fortement alcalines |
WO2009158617A1 (fr) * | 2008-06-27 | 2009-12-30 | Novozymes A/S | Souche de bacillus amyloliquefaciens |
WO2010006235A1 (fr) * | 2008-07-11 | 2010-01-14 | Novozymes A/S | Souche de bacillus velezensis |
WO2010106077A1 (fr) | 2009-03-17 | 2010-09-23 | Dequest Ag | Composition pour inhiber la formation de tartre de sel de calcium |
WO2011098579A1 (fr) | 2010-02-12 | 2011-08-18 | University Of Newcastle Upon Tyne | Composés à base de désoxyribonucléase batérienne et méthodes pour la désintégration et la prévention d'un biofilm |
WO2012112718A1 (fr) * | 2011-02-15 | 2012-08-23 | Novozymes Biologicals, Inc. | Réduction des odeurs dans les machines de nettoyage et les procédés de nettoyage |
CN105950495A (zh) * | 2016-01-31 | 2016-09-21 | 中国热带农业科学院热带生物技术研究所 | 一株甲基营养型芽胞杆菌及其在畜禽养殖废水处理中的应用 |
WO2017157771A1 (fr) * | 2016-03-14 | 2017-09-21 | Henkel Ag & Co. Kgaa | Procédé de lutte contre les mauvaises odeurs au moyen de spores bactériennes capables d'inhiber ou de prévenir la production de mauvaises odeurs |
EP3561032A1 (fr) | 2018-04-27 | 2019-10-30 | The Procter & Gamble Company | Nettoyants antimicrobiens pour surfaces dures comprenant des alkylpyrrolidones |
WO2021115912A1 (fr) | 2019-12-09 | 2021-06-17 | Basf Se | Formulations comprenant une polyéthylèneimine modifiée de manière hydrophobe et une ou plusieurs enzymes |
CN114410520A (zh) * | 2022-01-11 | 2022-04-29 | 山东蔚蓝生物科技有限公司 | 一株枯草芽孢杆菌及其在粪便堆肥除臭中的应用 |
-
2023
- 2023-10-11 WO PCT/EP2023/078168 patent/WO2024083600A1/fr unknown
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129328A2 (fr) | 1983-06-20 | 1984-12-27 | Olin Corporation | Détergents anioniques |
US5120326A (en) | 1989-06-30 | 1992-06-09 | Olin Corporation | Anionic polycarboxylated surfactants as dye-leveling agents |
US5376298A (en) | 1993-07-29 | 1994-12-27 | The Procter & Gamble Company | Hard surface detergent compositions |
WO2000003752A1 (fr) * | 1998-07-13 | 2000-01-27 | Life Science Tgo, S.R.L. | Bacteries utiles comme agent de neutralisation d'odeurs pour moquettes |
WO2003018733A1 (fr) | 2001-08-27 | 2003-03-06 | Ecolab Inc. | Melange d'agents de surface pour une utilisation dans des compositions fortement alcalines |
WO2009158617A1 (fr) * | 2008-06-27 | 2009-12-30 | Novozymes A/S | Souche de bacillus amyloliquefaciens |
WO2010006235A1 (fr) * | 2008-07-11 | 2010-01-14 | Novozymes A/S | Souche de bacillus velezensis |
WO2010106077A1 (fr) | 2009-03-17 | 2010-09-23 | Dequest Ag | Composition pour inhiber la formation de tartre de sel de calcium |
WO2011098579A1 (fr) | 2010-02-12 | 2011-08-18 | University Of Newcastle Upon Tyne | Composés à base de désoxyribonucléase batérienne et méthodes pour la désintégration et la prévention d'un biofilm |
WO2012112718A1 (fr) * | 2011-02-15 | 2012-08-23 | Novozymes Biologicals, Inc. | Réduction des odeurs dans les machines de nettoyage et les procédés de nettoyage |
CN105950495A (zh) * | 2016-01-31 | 2016-09-21 | 中国热带农业科学院热带生物技术研究所 | 一株甲基营养型芽胞杆菌及其在畜禽养殖废水处理中的应用 |
WO2017157771A1 (fr) * | 2016-03-14 | 2017-09-21 | Henkel Ag & Co. Kgaa | Procédé de lutte contre les mauvaises odeurs au moyen de spores bactériennes capables d'inhiber ou de prévenir la production de mauvaises odeurs |
EP3561032A1 (fr) | 2018-04-27 | 2019-10-30 | The Procter & Gamble Company | Nettoyants antimicrobiens pour surfaces dures comprenant des alkylpyrrolidones |
WO2021115912A1 (fr) | 2019-12-09 | 2021-06-17 | Basf Se | Formulations comprenant une polyéthylèneimine modifiée de manière hydrophobe et une ou plusieurs enzymes |
CN114410520A (zh) * | 2022-01-11 | 2022-04-29 | 山东蔚蓝生物科技有限公司 | 一株枯草芽孢杆菌及其在粪便堆肥除臭中的应用 |
Non-Patent Citations (11)
Title |
---|
ARTHUR LESK: "Introduction to bioinformatics", 2008, OXFORD UNIVERSITY PRESS |
DATABASE EMBL [online] 1 September 2013 (2013-09-01), HONG X: "Bacillus sp. V2A 16S ribosomal RNA gene, partial sequence.", XP093031817, retrieved from https://www.ebi.ac.uk/ena/browser/api/embl/KF279641.1?lineLimit=1000 Database accession no. KF279641 * |
DATABASE EMBL [online] 24 July 2022 (2022-07-24), GUO Z ET AL: "Bacillus siamensis strain HBUAS71050 16S ribosomal RNA gene, partial sequence.", XP093031813, retrieved from https://www.ebi.ac.uk/ena/browser/api/embl/OP002226.1?lineLimit=1000 Database accession no. OP002226 * |
GREENMAN, JOHN ET AL., JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, vol. 136, no. 6, 1939, pages 749 - 57 |
GUPTA ET AL., BIOTECHNOL. APPL. BIOCHEM., vol. 37, 2003, pages 63 - 71 |
HOFFMAN, W. S., J. BIOL. CHEM., vol. 120, 1937, pages 51 |
JOMKHWAN MEERAK ET AL: "Phylogeny of gamma-polyglutamic acid-producing Bacillus strains isolated from a fermented locust bean product manufactured in West Africa", THE JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY, vol. 54, no. 3, 1 June 2008 (2008-06-01), pages 159 - 166, XP055185138, ISSN: 0022-1260, DOI: 10.2323/jgam.54.159 * |
LARKIN, M. A.BLACKSHIELDS, G.BROWN, N. P.CHENNA, R.MCGETTIGAN, P. A.MCWILLIAM, H.VALENTIN, F.WALLACE, I. M.WILM, A.LOPEZ, R.: "Clustal Wand Clustal X version 2.0.", BIOINFORMATICS, vol. 23, 2007, pages 2947 - 2948 |
MCCLEARY, B. V, CARBOHYDRATE RESEARCH, vol. 67, no. 1, 1978, pages 213 - 221 |
MILLER, G. L: "Use of Dinitrosalicylic Acid Reagent for Determination of Reducing Sugars", ANALYTICAL CHEMISTRY, vol. 31, 1959, pages 426 - 428 |
VEHAPI, M.OZGIMEN, D, BULLETIN OF BIOTECHNOLOGY, vol. 1, 2020, pages 1 - 7 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020519288A (ja) | 洗浄のためにリパーゼ酵素を使用する方法 | |
WO2013113619A1 (fr) | Agent de rinçage liquide pour vaisselle stable au stockage contenant une protéase et une amylase | |
WO2013037609A2 (fr) | Procédé d'adaptation d'une enzyme hydrolytique à un constituant stabilisant ladite enzyme hydrolytique | |
WO2016087403A1 (fr) | Variants de protéases présentant un meilleur effet lavant | |
EP4045625A1 (fr) | Liquides contenant une hydrolase stable au stockage | |
AU2017248215A1 (en) | Enzymatic cleaning and sanitizing compositions and methods of using the same | |
WO2023199945A1 (fr) | Nouvelle lipase | |
WO2024083600A1 (fr) | Bactéries de lutte contre les odeurs | |
CN104755615A (zh) | 用于餐具洗涤的改进的方法 | |
CN111417707A (zh) | 储存稳定的酶制剂、其制备和应用 | |
US20240240115A1 (en) | Composition with improved moisture management performance | |
CN116568792A (zh) | 用于清洁的酶和酶组合物 | |
WO2017089162A1 (fr) | Variants de protéases à stabilité enzymatique améliorée dans les détergents et produits d'entretien | |
CN111269760B (zh) | 赋予洗涤后织物长效抗菌和抑制异味效能的洗涤剂组合物及异味评价方法 | |
WO2023199946A1 (fr) | Nouvelle lipase | |
US20240052270A1 (en) | Liquid composition comprising peptide aldehyde | |
WO2024012894A1 (fr) | Formiates d'alcanolamine pour la stabilisation d'enzymes dans des formulations liquides | |
WO2024033133A2 (fr) | Compositions enzymatiques contenant une amylase | |
WO2024175293A1 (fr) | Détergents et agents nettoyants comprenant de la dispersine | |
WO2024094735A1 (fr) | Polypeptides présentant une activité protéasique pour utilisation dans des compositions détergentes | |
CN114631528A (zh) | 液态抗生物膜组合物 | |
CA3218514A1 (fr) | Methode de nettoyage longue duree | |
WO2024094733A1 (fr) | Polypeptides présentant une activité protéasique pour utilisation dans des compositions détergentes | |
WO2024094732A1 (fr) | Polypeptides présentant une activité protéasique pour utilisation dans des compositions détergentes | |
DE102014206051A1 (de) | Proteasen mit verbesserter Wasserhärtetoleranz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23790554 Country of ref document: EP Kind code of ref document: A1 |